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Q U I L L  O N  S C A L P E L  This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
THE PACEMAKER 
AND THE SURGEON
The transvenous insertion of a per­
manent pacemaker is the commonest 
operation performed on the heart to­
day. Almost 10,000 patients in Canada 
have implanted pacemakers and each 
year about 100 additional persons per 
million will undergo an implantation. 
In most instances these are inserted by 
cardiac surgeons at large university 
centres. Recently, however, there has 
been increasing interest by, and pres­
sure upon, surgeons in smaller hos­
pitals with purely thoracic, vascular or 
general surgical experience, to implant 
pacemakers. In some centres a cardi­
ologist and a surgeon together implant 
the pacer. Few guidelines are available 
to assist the individual surgeon who 
embarks upon the procedure at a non­
teaching hospital. This expression of a 
personal philosophy concerning pace­
makers may save some surgeons con­
siderable grief and hardship during the 
early phase of their pacemaker pro­
gram.
It is our view that pacemakers should 
be inserted in a sterile operating 
theatre rather than in the radiology de­
partment or the cardiac catherization 
laboratory. A portable image intensi- 
fier and translucent table are required, 
and the operating room should be 
electrically grounded and provided with 
a reliable ECG monitor and defribril- 
lator.1 An anesthetist and/or cardi­
ologist must be present and prepared 
to administer appropriate drugs 
through an established intravenous in­
fusion. We routinely use local infiltra­
tion anesthesia, but if general an­
esthesia is preferred a temporary trans­
venous pacemaker should be inserted 
before operation. An external demand 
battery-powered pacemaker, equipped 
to provide variable rate and amplitude 
and with sterile connectors to the oper­
ating field must be present and all staff 
should be familiar with its operation. 
Pacemaker hardware, including acces­
sories, adapters, repair kits and in­
struction manuals should be readily 
available.
Choosing the appropriate pacemaker 
manufacturer and model may be frus­
trating since there are now over a 
dozen companies supplying the device 
in North America. Unless the surgeon 
and cardiologist are experienced, they 
can be influenced by the most persua­
sive salesman or captivating advertise­
ment. The decision requires a review 
of the current literature and the infor­
mation and advice provided by an 
established large-volume pacemaker 
clinic. The manufacturer chosen must 
provide a flexible range of pacing 
modes with units that are simple to 
connect and repair. They must allow 
for easy electrocardiographic interpre­
tation and simple mechanisms for fol­
low-up. These features require not only 
an energy source of proved durability 
but that there should be a dependable 
failure mode and a reliable method of 
predicting battery (pulse-generator) 
failure. Service and parts must be read­
ily available from either the company 
or its representative. There must be 
honest and rapid communication be­
tween the manufacturer and the sur­
geon. However, the onus is on the pace­
maker team; at present only 30% to 
40% of pacemakers in use have had 
adequate data forwarded to the manu­
facturers.2 The surgeon and cardi-
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ologist should be educated in pacer cir­
cuitry and electrophysiology by their 
university colleagues rather than by 
commercial salesmen. They should also 
be prepared to provide educational ma­
terial to their own patients and re­
ferring physicians. In-hospital teaching 
is the responsibility of the implanting 
surgeon, not the salesman.
A surgeon should not embark upon 
pacemaker implantation unless he and 
his cardiologist have already estab­
lished some means of accurate data re­
trieval in the follow-up period and some 
form of pacemaker-patient surveillance 
mechanism." It is estimated at present 
that 50% of patients with implanted 
pacemakers in North America are not 
followed up in any co-ordinated man­
ner.4 This state of affairs inevitably 
leads to unnecessary deaths, unneces­
sary emergency replacements, or, con­
versely, unnecessary premature re­
placements.
Replacement of a pulse-generator 
cannot now be performed simply be­
cause of one’s inability to interpret the 
electrocardiogram, nor should it be per­
formed at the suggestion of the pace­
maker company. Medicolegal restric­
tions prevent the manufacturer from 
publishing early information regarding 
malfunctions or premature failure. A 
reliable method of pacemaker surveil­
lance will allow for a uniform replace­
ment program. “Elective” replacement 
at industry-designated safe times can 
be performed to prevent catastrophic 
battery failure with return of symp­
toms. However, in this era of telephone 
monitoring such replacements are done 
only to relieve patient anxiety or be­
fore long journeys. Telephone surveil­
lance allows for extended battery lon­
gevity and patient security and elim­
inates emergency replacement by ac­
curately predicting impending pulse- 
generator exhaustion.5
Patients are admitted to hospital for 
pulse-generator replacements only if 
they are old and frail, or live at a dis­
tance. Otherwise, replacement can be 
performed as an out-patient procedure. 
A chest radiograph should be obtained
routinely to rule out lead fracture 
which can itself result in either failure 
to pace or battery depletion from ex­
cessive current drain. The surgeon 
should be completely familiar with the 
original indications for the pacemaker, 
the original type of pacemaker inserted 
and the threshold required for stimula­
tion at that time. All safety precautions 
must again be available during the 
period of transfer to a new power 
source. To increase pacer longevity, a 
reduced current output pacemaker 
should be available if the chronic thres­
hold determination is less than three 
milliamperes. It may be appropriate at 
this time to change the pacing mode 
from the original (e.g. from a fixed 
rate to a demand unit because of com­
petition). These decisions should be 
determined beforehand by consultation 
with the cardiologist. It is assumed that 
the new pacemaker team will famil­
iarize themselves with the surgical 
technique. The surgeon should be aware 
that he is inserting an electronic device 
that, in terms of energy reserve, cur­
rent drain and component stability, is 
literally failing from the moment of 
manufacture. Constant surveillance is 
therefore mandatory. Continual patient 
reassurance and communication with 
family physicians become essential 
since the patient becomes emotionally 
dependent on the surgeon, attributing 
many aspects of ageing to the pace­
maker or its insertion, and may suffer 
anxiety should the referring physician 
appear uninvolved or uninterested.
Canadian surgeons should also be 
aware that pacemaker insertions and 
replacements command high tariffs in 
the United States. The highly inflated 
American medical economy and com­
petitive electronics industry may inter­
fere with accurate perspective in cer­
tain decisions concerning pacemaker 
therapy. It is difficult to know if the 
indications for pacemakers are truly 
expanding or if the newer, more 
sophisticated, more expensive circuits 
allow a wider range of application. 
Each pacemaker insertion should be 
considered an evaluation, with each pa-
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tient validating his own unit at his own jeopardy; no manufacturer can afford to bench-test or animal-test any pace­maker for a four- or five-year period with any statistically significant num­ber of units.2- 6 The new and innocent pacemaker team should also be aware that many of the claims of manu­facturers regarding reliability are based solely upon the experience of a few validating centres which have large clinics and in-depth experience, allow­ing them to follow up patients consider­ably better and longer than most teams. They may also be reporting on proto­type models that are not even available to the average surgeon and may there­fore create erroneous impressions re­garding durability. Those familiar with pacemaker electrophysiology will also realize that certain features advertised by manufacturers may have little im­portance and are simply mechanisms to circumvent patent rights.6The mode of pacemaker failure is now fairly standardized and based on rate decrease with energy depletion; this has allowed the trans-telephone concept of follow-up to expand rapidly. However, it is not absolutely necessary for a new pacemaker team to establish a telephone surveillance mechanism. There are many efficient ways to con­trol pacemaker patients closely and provide them with security and maxi­mum pacemaker longevity.7 However, the importance of some follow-up pro­gram can be realized if it is admitted that the initial pacemaker insertion is merely the start. Scarcely has pace­maker therapy been established in a hospital than the collection of informa­
tion becomes pushed into the back­ground by the growing volume of pa­tients and their pacemaker problems. There is an attendant loss of efficiency and an increase in emergency pulse- generator replacements. We strongly endorse and support the efforts of small-volume pacemaker teams at non­teaching hospitals provided they allow for liaison with a central computer- based university hospital pacemaker clinic. This arrangement should furnish maximum exchange of information and efficiency of data retrieval and patient recall.s
B. S. Goldman 
E. J. Noble 
D. C. MacGregor
Toronto General Hospital,Toronto, Ont. M5G 1L7.
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the only absorbable 
haemostat that 
meets all 
these criteria:
absorbed completely in four to six weeks; 
liquefies within two to five days when used as 
a surface dressing
safe as a permanent packing in any tissue; 
won’t interfere with bone regeneration or cause 
cyst formation
effective dry or moist
compatible with thrombin solution
a naturally occurring substance; non-irritating; 
neutral pH
stimulates the natural clotting mechanism
may be cut, molded to shape, and sutured 
when necessary
available as sponges, packs, prostatectomy 
cones, sterile and non-sterile powder, to meet 
most surgical needs
sealed in individual envelopes to insure sterility
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available in a wide variety of shapes, sizes, and forms suitable 
to most areas of surgery where haemostasis is desired.
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for general surgery
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for general and 
neurological surgery
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box of 4 sponges
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neurological surgery
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size 12-7 mm 
20 x 60 x 7 mm 
box of 4 sponges No. 7853 
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dead space
obliterating
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80 x 250 x 10 mm 
box of 6 sponges No. 7862
specially prepared for dry appli­
cation and emergency haemostasis
Sterile Compressed 
Sponge, 
size 100 
80 x 125 mm
box of 6 sponges No. 7865
for use with Foley catheter
Prostatectomy 
Cones, 
size 18 cm 
(7 in.) in diam. 
box of 6 cones No. 788
for use with Foley catheter
Prostatectomy 
Cones, 
size 13 cm 
(5 in.) in diam. 
box of 6 cones No. 7880
for dental surgery
Dental Pack, 
size 2
10 x 20 x 7 mm 
jar of 15 No. 7867
non-haemostatic 
for ocular surgery
Ophthalmic 
Sterile Gelfilm 
25 x 50 mm 
box of 6 No. 78'
promote healing in chronic 
leg ulcers
Sterile Powder 
ja r containing 1 g
for dental surgery
Dental Pack, 
size 4
20 x 20 x 7 mm 
jar of 15 No. 7868
l n
  No. 7876
Precautions
Geffoam s
dica te ii V
bu minimal
oral haemostatic for 
gastroduodenal bleeding
Non-Sterile Powder 
box containing 10 g No. 7877
non-haemostatic for repairing 
defects in dura and 
pleural membranes
Sterile Gelfilm 
size 100 x 125 mm 
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be m snug contact with the bleeding surface m order to  be effective 
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FATE OF ARTICULAR CARTILAGE IN JOINT TRANSPLANTATION*
G. J. LLOYD, M.B., F.R.C.S.[Eng. &C],f D. R. McTAVISH, M.D., F.R.C.S.[C],t S. SORIANO, M.D., F.R.C.S.[C],§ A. M. WILEY, M.B., M.Ch., F.R.C.S.[Eng. & C]t and M. H. YOUNG, M.B., Ch.B., F .R .C .S .,Toronto, Ont.
Summary: The behaviour of the articular car­
tilage of joint transplants was observed in an 
animal model. Fresh plugs of costal graft were 
impacted rigidly into the patellar surface of the 
femur and exposed to normal activity for as long 
as two years. Under these circumstances auto­
grafts and allografts appeared viable and in the 
latter there was no evidence of any immu­
nologic reaction even after this long period. An­
other series of animals suffering from surgically 
induced hyaline cartilage degeneration exhibited 
fibrous healing of the defects when the joint 
was properly aligned. Such healing contributed 
to resurfacing of the intact joints when plug 
grafts of cartilage were used.
Resume: Les auteurs ont etudie chez des ani- 
maux le comportement du cartilage articulaire 
dans les greffes d'articulations. Its ont insere un 
fragment de cote, par impaction, dans la face 
rotulienne du condyle femoral. Les animaux ainsi 
operes ont ete soumis a une activite normale, 
allant jusqu'a deux ans. Les autogreffes et les 
allogreffes ont ete viables dans ces condi­
tions et, meme dans le cas des allogreffes, on 
n'a note aucun signe de rejet apres une aussi 
longue periode. Chez un autre groupe d'ani- 
maux qui presentaient une degenerescence du 
cartillage hyalin causee par une intervention 
chirurgicale, on a note une cicatrisation fi- 
breuse des solutions de continuity apres que 
I'articulation eut ete alignee convenablement. 
Cette forme de reparation a contribue a retablir 
la surface des articulations intactes quand on 
avait recours a des greffons osteocartilagineux.
In spite of the technical improvements in artificial joints, the surgeon must
‘ Supported by Howard Cane Award from the Rehabilitation Foundation for the Disabled and a research grant from the Ontario Ge­riatric Research Society.
fAttending Surgeon (Orthopedics), Toronto Western Hospital, Toronto, Ont.
JOrthopedic Surgeon, Kitchener-Waterloo Hos­pital, Kitchener, Ont.
§Orthopedic Surgeon, York County Hospital, Newmarket, Ont.
*!Senior Lecturer, University Department of Orthopaedics, University of Edinburgh, Edin­burgh, Scotland.
Reprint requests to: Dr. A. M. Wiley, Suite 101, 25 Leonard Avenue, Toronto, Ont. M5T 2R1.
still occasionally replace a joint with a human allograft. Joint transplantation certainly must be considered in cases of massive osteochondritis dissecans, post-traumatic defects and certain large tumours of articular and osteoarticular areas that are either non-malignant or 
of low-grade malignancy. Nevertheless, without a full appreciation of all the factors involved, there is little justifica­tion for the occasional joint transplant. Joint conditions are not an immediate matter of life and death, and alternative procedures can be employed. The alter­natives to joint transplantation are more attractive since they offer the prospect of earlier rehabilitation and they are readily available. These fea­tures, together with the natural distaste for removal of cadaver joints and their implantation in another individual, have had the effect of creating less interest in the investigation of total joint allo­grafts than in the subject of vital organ transplantation.Human joint transplantation has been used extensively by Volkov and Ima- maliev.1’ 2 They have reported on the use of cadaver joints followed up for a period of three years. Although in many patients good results were claimed, de­generative changes were seen on the ar­ticular surfaces in the three-year period. Reports of autopsy studies of the joint surfaces are difficult to compile. Earlier clinical experience with whole-joint transplants was reported by Lexer. 3 Other authors, notably May, 4 Storig/’ and Bonney and Laurence, 6 have re­ported their clinical experiences. Re­placement transplantation of finger joints with toe-joint autografts has been reported by Erdelyi, 7 9 Graham and Riordan, 10 Blokhin, 11 Parrish12 and Ottolenghi, 13 but digital autografts can hardly be compared with the allografts to a weight-bearing surface.There is no longer speculation about the fate of the bone in joint allografts.
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The bone dies and is replaced by the 
host at varying speeds with varying 
completeness. In experimental animals 
deep freezing and freezing, irradiation 
and probably tissue-typing are known to 
alter the speed of revascularization of 
the bone graft.14- 1 3 The influence of 
such physical processes upon the viabi­
lity of chondrocytes is not adequately 
described though it is almost certainly 
deleterious.
As well, there are few descriptions of 
the hyaline cartilage after prolonged im­
plantation. However, the behaviour of 
articular cartilage in whole- or half­
joint transplants has been repeated­
ly observed in the experimental ani­
mal.1 1,19 The construction of many of 
the animal experiments has introduced 
mechanical factors which may have in­
terfered with results. The immunologic 
aspects of cartilage transplantation 
have been outlined by Peer-0 and Wood­
ruff21 and explored by the increasingly 
elegant experiments of Craigmyle,22 
Bonney and Laurence® and Chesterman 
and Smith.23 Gross and Langer24 have 
shown that there is indeed an immuno­
logic rejection process against articular 
cartilage. However, the extensive work 
of Gibson2r>- 20 has tended to minimize 
the importance of this phenomenon. The 
position of the hyaline cartilage in a 
whole-joint transplant is well summar­
ized by Burwell27 in a review article.
This paper is concerned with the long­
term survival of hyaline cartilage as a 
graft and describes experiments car­
ried out to determine the effect of joint 
mechanics upon the healing of carti­
lage; these studies appear relevant to 
the healing of a cartilage graft.
E xp er im e n t s
Materials and Methods
In the construction of a model for 
the long-term study of hyaline carti­
lage grafts we have assumed that the 
grafted surface will be in contact with 
subchondral bone, because, for clinical 
purposes, there is great difficulty in 
fixing one hyaline cartilage surface 
directly upon another. In clinical joint
transplantation it has been usual to 
use a joint surface which includes a 
layer of subchondral bone of varying 
thickness. This enables a transplant to 
be fixed in the host with a fair degree 
of confidence. In these grafting experi­
ments, plugs of costal cartilage were 
removed from the same animal or from 
another animal or from a different spe­
cies. In the animal experiments we 
used adult mongrel dogs and it was our 
practice to mobilize the knee joint as 
soon as possible and to encourage the 
animal to exercise; no plaster casts 
were used. In a xenograft series rab­
bit rib cartilage was used after remov­
ing the perichondrium.
Staining Techniques
To facilitate examination of the col­
lagen fibre network in hyaline cartilage 
we used the technique using polarized 
light described by MacConaill.2*
For studying ground substance muco­
polysaccharide the following stains were 
used: toluidine blue29'31 and alcian blue 
— a phthalocyanine dye introduced by 
Steedman32 and Zugibe, Brown and 
Last.33
In the long-term experiments with 
allografts we used a radioactive sulfur 
( 3r,S04) technique as follows: Before 
fixation each specimen (i.e. each half­
wedge) was incubated at 37° C. in 10 
ml. Tyrode’s solution containing 10 /xCi 
3r’S04 for four hours in a thermostati­
cally controlled water bath with conti­
nuous agitation. The specimens were 
then rinsed in cold carrier-free isotonic 
sulfate and allowed to stand overnight 
in this solution in the refrigerator in 
order to remove excess isotope not chem­
ically bound in the tissue. The following 
day the specimens were rinsed again in 
carrier-free sulfate and then fixed in 
Bouin’s solution.
After fixation the specimens were de­
calcified in EDTA, dehydrated and em­
bedded; sections approximately 0.5 g  
thick were prepared in a plane perpendi­
cular to the articular surface. These sec­
tions were mounted in the usual way 
and stained, some with hematoxylin
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Fig. 1.—Degenerative ulcer on the patella following persistent medial dislocation.
and eosin and some with saffronin “ 0 ” 
and brilliant green.
In addition autoradiographs were 
prepared by the dipping technique. 
These were exposed in the dark in the 
refrigerator for periods of three to six 
weeks before being developed and fixed. 
Finally they were stained through the 
emulsion with hematoxylin and eosin.
C o n t r o l  E x p e r i m e n t s
A total of 70 mongrel dogs was used. 
In six dogs portions of articular carti­
lage were excised exposing the sub­
chondral bone on the patellar surface 
of the femoral condyles. The patellar 
mechanism was restored to its normal 
position and the animal was freed.
It proved difficult to create a regu­
lar area of degeneration on articular 
cartilage on the surrounding articular 
surfaces for the purposes of study. 
Lacerating menisci and cutting the 
cruciate and collateral ligaments were 
tried but were ineffective in this re­
spect. Persistent medial displacement 
of the patella, however, resulted in the 
development of a traumatic ulcer on
the inferomedial patellar surface. It 
was assumed that the extent of the 
ulcer was related to the activity of the 
dog, but naturally this could not be re­
peatedly supervised for a period of 
many months. Four dogs survived a 
medial patellar displacement for one 
year (Fig. 1).
In a further series, each dog had 
been subjected to the operation of me­
dial displacement of the patella three 
to six months previously and had de­
veloped a degenerative ulcer on the in­
feromedial pole of the patella. The pa­
tella was then surgically returned to 
its normal position and the dog was 
encouraged to move about. At the time 
of replacement we took photographs 
or made sketches of the appearances of 
the ulcer. When the subchondral bone 
was seen exposed in the ulcer it was 
drilled with a dental drill.
Results
At four months, in those animals 
subjected to simple excisions of por­
tions of hyaline cartilage from the fe­
moral condyles, fibrous tissue healing
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of the defect was noted. The articu lar 
surface was smooth and glistening. No 
degenerative changes were noted on 
the adjacent patellar surface. Dogs 
subjected to medial patellar displace­
m ent and later realignm ent presented 
some m anagem ent problems. I t was 
not always possible to re tu rn  the pa­
tella perm anently to its normal posi­
tion a f te r  such a long period of dis­
placement. For th is  reason we rejected 
six of the dogs, leaving only three su r­
vivors fo r final study. One animal was 
killed four m onths a fte r  the patella 
had been retu rned  to its normal posi­
tion and had been debrided. A nother 
was sacrificed one m onth afte r the re ­
placement, and the th ird  three m onths 
later.
A t autopsy the surface of the patella 
a t the site of the traum atic  ulcer was 
smooth and glistening and, indeed, it 
was difficult to detect any change in 
the appearance of the articu lar su r­
faces a t f ir s t  glance. A t four m onths 
the surface w as covered by a layer of 
m aterial th a t histologically resembled 
fibrous tissue in terspersed with a few
F ig . 2.—A ppearance of th e  p a te l la r  su rfa c e  
a f t e r  d eb ridem en t and rep lacem en t. H ea lin g  
a r t ic u la r  su rface .
chondrocytes, i.e. fib rocartilage  (F igs. 
2 and 3).
F rom  these experim ents we con­
cluded th a t cartilage defects will heal
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themselves by a process of fibrocartila­
ginous resurfacing, provided that joint 
mechanics can be approximated to 
normal and provided that the subchon­
dral bone is exposed to repair.
Further, we concluded that the in­
sertion of a plug of hyaline cartilage 
into the patellofemoral joint did not of 
itself lead to degenerative change pro­
vided the joint mechanics had been re­
stored to normal.
E x p e r im e n t s  W it h  H y a l i n e
C a r t il a g e  A uto g rafts
In 16 adult dogs the costal cartilage 
was inserted as a plug type of graft 
into the patellar surface of the femur. 
The patella was replaced in 10 and ex­
cised in six dogs, all of which were en­
couraged to walk freely during their 
convalescence. These experiments ex­
tended over a 24-week period. Speci­
mens were obtained by sacrificing ani­
mals at six, 14, 18 and 22 weeks, as 
well as 24 weeks.
Results
In all the dogs in which the patella 
was relocated after the grafting proce­
dure, the graft remained in place. In 
the six animals subjected to patellec­
tomy the graft became dislodged. Nor­
mal joint mechanics appeared essen­
tial to the incorporation of cartilage 
grafts inserted by this technique. After 
sacrifice, specimens were obtained by 
excising the entire lower end of the 
femur, bisecting it and staining it with 
tetrachrome stain. In the six-week spe­
cimen the plug graft appeared to be 
inert and there was no gross or micro­
scopic evidence of reaction between the 
graft and host. With the tetrachrome 
stain the chondrocytes appeared to be 
viable and the ground substance took 
up the stain. At 16 weeks the grafts 
were incorporated but could be pried 
loose, leaving a defect in the femoral 
condyle. The defect was lined by a 
glistening membrane, forming a type 
of capsule. On microscopic examination 
this was composed of white fibrous 
tissue (Fig. 4).
At 18 weeks it was more difficult to
Fig. 4.—A cartilage autograft in the femoral 
articular surface 16 weeks after insertion. The 
graft could be pried loose.
remove the graft; collagen fibres in 
this “white lining” blended into the 
margin of the graft, which itself clear­
ly maintained its outline. Cartilage on 
the surface of the adjacent (donor) 
condyle had made no effort to blend 
into the surface of the graft (Fig. 5).
Fig. 5.—At 16 weeks a cleft exists between 
the graft and the femoral articular surface
September 1973 JOINT TRANSPLANTATION 311
Fig. 6.—A cartilage autograft at 26 weeks. The depths of the graft and the cancellous bed 
are blending. A thin fibrous layer can still be seen marginally.
At 24 weeks the graft appeared to be 
firmly embedded. In sections taken 
from the insertion of the graft and 
stained by von Kossa’s stain and hema­
toxylin and eosin, a well-defined junc­
tion was still plainly apparent between 
the graft and the recipient. This con­
sisted of fibrous tissue and large ca­
pillaries. In a high-power view of this 
area the peripheral chondrocytes in the 
graft were undergoing hydropic degen­
eration and were being invaded by the 
marginal fibrous tissue (Fig. 6). This 
invasion explained the firm bond that 
developed between the graft and the 
donor bone. The viability of the 24- 
week graft was suggested by the radio­
active sulfur technique.
At this 24-week period, to the naked 
eye the surface of the graft remained 
flush with that of the host and its ac­
ceptance seemed complete. Nevertheless, 
we could not predict the effect of long- 
sustained physiologic demands upon a 
tissue which had been removed from 
the costochondral area and impacted 
into the patellar surface of the femur.
A l l o g r a f t  (H o m o g r a f t ) 
E x p e r im e n t s
The technique for grafting was as 
follows: Dogs were anesthetized in
pairs. A plug or cylindrical portion of 
cartilage was excised with a fine pointed 
scalpel from the fourth or fifth costo­
chondral junction of each dog and 
placed in normal saline after removal of 
the perichondrium.
The patellofemoral articulation of the 
knee joint was exposed through a me­
dial parapatellar incision. Using a small 
hand drill a defect 5 mm. in diameter 
was drilled into the patellar surface of 
the femur, extending into the subchon­
dral bone. The plug of costal cartilage 
from the other member of the pair was 
inserted and cut level with the adjacent 
cartilage surface. Incisions were re­
constituted.
Of the 22 dogs subjected to this proce­
dure, 20 survived. One animal died as 
the result of hemothorax and the second 
was sacrificed when the knee joint be­
came infected. In the remaining animals
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the wounds healed without problem. No 
attempt was made to immobilize the 
joint and the animals were weight bear­
ing within three to four days.
Dogs were sacrificed at three, 12, 16, 
20, 26, 39 and 52 weeks. Six dogs were 
allowed to survive for two years and 
were then sacrificed. In each case, im­
mediately before death the animals were 
observed walking and running, and the 
limb was put through a passive range of 
movement and compared with its oppo­
site limb. When the knee joint was 
opened post mortem the synovium in 
all cases was normal. Photographs of 
the graft were taken immediately after 
opening the joint; it was noticed that 
delay appeared to affect its appearance. 
Finally, the grafted area was removed 
and sectioned as described previously.
Results
The behaviour of all allografts was 
assessed by studying: (1) mechanical 
fixation, (2) chondrocyte topography, 
(3) the arrangement of the collagen f i ­
bres within the cartilage matrix, (4) 
the quantity of ground substance of the
matrix relative to the adjacent host 
cartilage and (5) the presence or ab­
sence of changes possibly due to tissue 
rejection (these changes may be re­
flected in failure of any of the factors 
referred to above).
Mechanical fixation of the graft.— 
In no case had the graft become dis­
lodged and macroscopically all appeared 
to be firmly attached to the host carti­
lage. Sections from all the dogs sacri­
ficed within the first three months 
showed separation of the graft from the 
host tissue, possibly attributable to the 
action of the microtome. This finding is 
similar to that encountered in autograft 
experiments. It was not evident in dogs 
sacrificed after longer periods.
After a three-month interval the 
graft remained firmly fixed in all the 
animals for the duration of the experi­
ment.
Chondrocyte topography.— The work 
of Benninghoff34 showed the arrange­
ment of collagen fibres within articular 
cartilage. It is believed that this 
arrangement leads to the topographic 
orientation of the chondrocytes.
Fig. 7.—Allografted chondrocytes fail to reorient themselves (x 250).
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Fig. 8a Fig. 8b
Fig. 8.—(a) An unstained section of hyaline cartilage examined with polarized light show­
ing the lamina splendens appearing as a bright line on the surface, (b) Unstained section of 
costal cartilage graft, also examined with polarized light, showing the absence of lamina splen­
dens.
In no specimen in this series was 
there any evidence that the chondro­
cytes of the graft were assuming any 
particular topography; they retained 
the orientation and appearance of costal 
cartilage (Fig. 7).
Collagen fibre arrangement.— Sec­
tions taken in a number of directions 
were prepared by MacConaill’s method 
and examined using a polarized light 
source as well as by plain light transil­
lumination.
In all animals a lamina splendens 
could be demonstrated in the most su­
perficial layer of the articular cartilage 
of the host. This appeared as a thin 
bright line at the articular surface of 
the cartilage. However, this feature was 
not evident in the transplanted cartilage 
(Fig. 8). We could not detect a similar 
anastomotic network in the transplanted 
costal cartilage by either of these two 
techniques.
Ground substance.— Using sections
fixed with alcohol and stained with to- 
luidine blue, three months after graft­
ing the transplanted cells appeared to 
be alive as they were producing muco­
polysaccharide ground substance.
The junctional area between graft 
and host cartilage three months after 
grafting (Fig. 9) shows the intensity 
of the staining of the graft (on the left) 
as compared with the host cartilage (on 
the right). This indicates that the 
grafted cells were alive and producing 
ground substance.
However, after a year, and also after 
two years, depletion of matrix was evi­
dent in the graft and also on the surface 
formerly lined with perichondrium 
(Figs. 10 and 11).
By staining sections with alcian blue 
we reached the same conclusions regard­
ing the behaviour of the ground sub­
stance as from using toluidine blue, 
namely that during the initial six 
months after grafting the cartilage cells
314 THE CANADIAN JOURNAL OF SURGERY Vol. 16
continued to produce matrix ground 
substance, but in the second six months 
this action was not maintained.
E x pe r im e n ts  W ith  X enografts
In 12 mongrel dogs we inserted plugs 
of rabbit costal cartilage into the femur 
by a technique similar to that employed 
in the autograft group. The rabbit costal 
cartilage with the perichondrium re­
moved was shaped into a dowel and 
driven into a defect created on the pa­
tellar surface of the dog’s femur. The 
dogs were killed three weeks to six 
months after the transplant. Immediate­
ly before sacrifice they were photo­
graphed walking and running and the 
limb was put through a passive range of 
motion to compare the joint with its 
normal fellow. After sacrifice the joint 
was inspected and the grafted area re-
Fig. 9.—The functional zone between the 
allograft on the left and the femoral articular 
surface on the right. Ground substance stain­
ing is intense.
1
v*Fig. 10.—An allograft margin at one year showing depletion of the matrix (x 250).
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Fig. 11.—A two-year allograft depressed below the articular surface. The centre of the 
graft appears viable. Perichondrial and marginal ground substance is depleted.
moved, as in the allograft experiments. 
One of the dogs was excluded from the 
study because of a joint infection. Sev­
eral of the others developed a respira­
tory infection which may have been epi­
demic and these dogs were removed 
from the series also. Twelve knees were 
available for macroscopic and histologic 
examination. In all of these dogs the 
graft had remained in situ.
Results
In the dogs with xenografts rapid 
changes in the microscopic and macro­
scopic appearance of the grafts made 
special collagen stains unnecessary.
In five knees the graft appeared 
grossly normal with respect to colour, 
consistence, shape and size. However, 
the femora of the remaining specimens 
showed obvious macroscopic changes, 
including softening, resorption, loss of 
sheen and discolouration. These changes 
were not directly related to the time in­
terval after grafting or to animal sur­
vival. Thus some of the grafts pre­
sented a relatively normal appearance
after three months, whereas others 
showed the obvious changes referred to 
above (Fig. 12).
Microscopically the changes were 
more striking in those grafts where the 
gross specimens had appeared normal. 
As early as three months after insertion, 
changes appeared within and around 
the graft itself. There were early signs 
of resorption of the graft with a moder­
ate inflammatory reaction and a fibri­
nous layer covered the articular surface. 
In many sections no viable cells could be 
found in any of the specimens at three 
weeks, although in others we found a 
few viable cells in the centre of the 
grafted area at this period. In these 
sections the matrix stained poorly. All 
specimens showed varying degrees of 
graft resorption and the grafts were in­
filtrated from all sides by chronic in­
flammatory cells and by vascular and 
fibrinous tissues. In some sections this 
reaction appeared to be more intense 
on the articular surface, but the chon- 
drosynovial junction also showed chro­
nic inflammatory changes and vascular
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Fig. 12.—The femoral surface at 12 weeks 
showing xenograft failure.
Fig. 13.—Failure of a xenograft; appearance 
at 12 weeks (x 25).
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Fig. 14.—The junctional zone of a xenograft and the femoral bed showing intense reaction -yi 
at 10 weeks (x 25).
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Fig. 15.—High-power view of Fig. 13 (x250).
infiltration (Figs. 13-15). In some speci­
mens a single layer of cells appeared to 
spread across the''margin of the femur 
towards the graft (Fig. 16). The pos­
sibility exists that this layer of pannus 
may influence the intensity of the re- 
sorptive phenomena.
The changes in the xenografts varied 
considerably in intensity and bore no 
apparent relationship to the time after 
grafting or to the duration of the ani­
mals’ survival. As with allografts, we 
found no evidence that the cells of the 
graft realigned themselves according to 
the stresses imposed upon them.
D iscussion
The application of animal experiments 
to human clinical experiences is never 
entirely satisfactory. Nevertheless, the 
acquisition at autopsy of sufficient hu­
man joint transplants seems so remote 
that further observation of long-term 
cartilage transplants must come from 
the laboratory.
For our experiments the knee joint 
of the dog was chosen because of its 
relatively large size and easy accessi­
bility. Although the patellofemoral com­
ponent is certainly not weight bearing, 
it is subjected to considerable pressure 
forces.
We would emphasize that the re­
sponses described are the sequelae to 
immediate transplantation of fresh car­
tilage into the subchondral bone zone 
of a recipient. Under consideration have 
been such factors as the spontaneous re­
pair of hyaline defects, cartilage-to-car- 
tilage healing at the edge of a graft, 
the behaviour of non-articular cartilage 
as a graft, the effects of joint surface 
incongruity and the possibility of the 
homograft reaction after insertion for 
a prolonged period in a functioning 
joint. Many, if not all, of these factors 
must come into operation in joint trans­
plantation, although not necessarily 
when one joint is totally replaced with 
another.
It is clear that, short of plug graft­
ing by the technique described, hyaline 
cartilage requires a subchondral bony 
layer, i.e. an osteocartilaginous block, 
for clinical transplantation. With to­
day’s therapeutic armamentarium there 
should be no particular difficulty in 
providing rigid fixation of such a graft
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to permit invasion and replacement of 
the composite transplant.
The ability of traumatic defects of 
articular cartilage to heal with hyaline 
cartilage has not been established. Mea- 
chim33 showed that scarification of 
rabbit femoral hyaline cartilage leads to 
a local area of chondrocyte death with­
out any evidence of healing. In his ex­
periments the injury had not extended 
to the subchondral zone and the joint 
mechanics were apparently normal. It 
is quite apparent that hyalins cartilage 
defects extending to subchondral bone 
quickly become filled with fibrous tissue 
and occasional chondrocytes, the result­
ing repair being, in some cases, indistin­
guishable from the neighbouring sur­
faces. These experimental findings are 
similar to those of Ito,36 Shands,37 Ben­
nett and Bauer38 and Key.39
Pridies’ “ debridement” procedure 
upon the knee joint, as reported by 
Imsall,4" is based upon such experi­
mental findings. Again experimentally, 
the importance of activity in the re­
storation of an injured and a grafted 
surface was illustrated by the appear­
ance of the femoropatellar surface in 
survivors and also by the complete fail­
ure of grafts when the patella was ex­
cised, whereas surface erosions were 
noted to heal when joint mechanics were 
restored to normal. While there have 
been comparatively few experiments to 
support this work,41 Mooney and Fer­
guson42 reported similar findings in 
their study of the repair of artificially 
produced defects.
In the clinical context Nissen43 has 
repeatedly described signs of joint space 
recovery following realignment proce­
dures for degenerative arthritis. In 
spite of this, hyaline cartilage suffers 
adversely when subjected to undue pres­
sure, such as occurs in cases of joint in­
stability, or where irregularities have 
developed in the joint surface. Salter 
and Field44 and Trias45 demonstrated 
the adverse effect of persistent pressure 
on articular cartilage in experimental 
animals, a phenomenon noted constantly 
in clinical practice.
In conclusion, therefore, it seems like­
ly that in the experimental animal the 
margins of an insert, whether cartilagi­
nous or osteocartilaginous, are filled by 
reparative fibrous tissue containing 
some chondrocytes, the surface of which 
will become smooth provided that joint 
activity returns and the joint itself is 
stable and properly aligned.
The use of non-articular cartilage for 
resurfacing joints has raised doubts 
about its durability and given rise to 
discussion about differentiation. Lem- 
perg, Hiertonn and Garmer46 described 
resurfacing in the hip joint with costal 
cartilage while Pap and Krompecher17 
emphasized the importance of function 
upon the surviving chondrocytes in this 
sort of graft. It is apparent that even 
after two years of function, costal allo­
grafts still show no tendency to realign­
ment or differentiation. This passive 
behaviour may, perhaps, be considered 
favourable and certainly convenient for 
it may enable the rib cage to be used as 
a donor site for clinical purposes.
There is much controversy about the 
role of rejection phenomena in cartilage 
grafting. It may be said that until re­
cently there has been little direct evi­
dence of their existence at all in carti­
lage. Gibson’s26 detailed observations 
over a period of years failed to discover 
convincing evidence of any such re­
action, either in patients or in experi­
mental models. Probably as the result 
of the protective matrix, chondrocytes 
enjoy a privileged position. Neverthe­
less, for hyaline cartilage to remain per­
manently free from rejection would con­
fer upon it powers that are unique. Ex­
periments have shown the gradual “de­
generation” of long-term allografts even 
after 500 days.19’ 47 Such degeneration 
has been reported from the late observa­
tion of transplanted joints in clinical 
practice. Recent studies of Gross and 
Langer24 using the immunofluorescent 
technique show definite rejection phe­
nomena towards cartilage grafts. With 
the technique used in our own experi­
ments over a period of two years no di­
rect evidences of rejection phenomena 
were seen, and until the immunofluores­
cent studies mentioned above were re-
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ported we concluded that rejection was 
not to be considered seriously in the 
long-term survival of joint grafts in 
clinical use. The possibility exists that 
some of the reactions described in the 
previous experiments may have arisen 
from infirm graft fixation rather than 
rejection, a factor that has entered into 
the design of many cartilage-to-carti- 
lage experiments in the past. McKib- 
bin,4s working with allografts in ma­
ture sheep, demonstrated collections of 
round cells in the subchondral bone 
adjacent to the graft at 17 weeks. His 
grafts were secured with silk sutures. 
The round cell aggregation diminished 
as the experiments were continued but 
there were few long-term survivors. 
McKibbin’s subsequent experiments 
with immature cartilage showed more 
intense response in the host, especially 
when the implanted graft had subsided 
below the joint surface, possibly reduc­
ing its vitality. These findings have not 
received confirmation.
This work was directed by one of us (A.M.W.) 
while the others, succeeding one another, were 
Clinical Research Fellows at the Toronto West­
ern Hospital.
The authors gratefully acknowledge the 
assistance provided by the Departments of 
Pathology, Nuclear Medicine and Medical Pho­
tography, Toronto Western Hospital.
The long-term continuance of these experi­
ments would have been impossible without the 
co-operation of the staff of the Coutts Re­
search Laboratory at the Toronto Western 
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Summary: Abdominal wall hematoma represents 
an unusual, infrequently encountered clinical en­
tity in which early non-operative diagnosis is 
made on few occasions. The condition is briefly 
mentioned in standard textbooks of surgery and 
clinicians should be aware of its possible oc­
currence.
Three cases are reported, of which two were 
in the lateral abdominal wall, a rarer condition. 
The diagnosis in one case was made by angio­
graphy, which has not been reported previously.
The etiology, pathology, clinical symptoms, 
treatment and prognosis of the abdominal wall 
hematoma are reviewed.
Resume: L'hematome de la paroi abdominale est 
une entite clinique exceptionnelle et rarement 
observee a propos de laquelle un diagnostic 
conservateur precoce est porte en quelques oc­
casions seulement. Cette pathologie est brieve- 
ment mentionnee dans les trades classiques de 
chirurgie, mais les cliniciens devraient etre au 
courant de sa survenue possible.
Les auteurs en presentent trois cas, dont deux 
etaient situes dans la paroi abdominale laterale, 
ce qui est une localisation plus rare. Un cas est 
bien documents et a ete diagnostique par angio- 
graphie qui, comme adjuvant diagnostique, n'a 
jamais ete signale auparavant.
Les auteurs passent en revue I'etiologie, la 
patholegique. les symptdmes cliniques, le trai- 
tement et le pronostic de l'hematome de la pa­
roi abdominale.
H e m a t o m a  of the abdominal wall in­
volving the rectus abdominis muscle is 
an uncommon but not a rare entity. In 
a review of the subject in 1938, Payne1 
observed that hematoma of the rectus 
abdominis muscle was known to the 
Greeks in the fifth century B.C. and 
Hippocrates was among the first to de-
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scribe the condition accurately. Leonar­
do da Vinci wrote on the subject in 1519 
and a description of it is to be found in 
the works of Galen.1
The true incidence of hematoma of 
the abdominal wall is difficult to ascer­
tain. Approximately 500 cases had been 
recorded in the world literature up to 
1970 as sporadic reports. The condition 
is probably more common than this, 
however, because minor amounts of 
bleeding can occur without causing sig­
nificant symptoms.
One of the most important papers on 
this subject remains that of Cullen and 
Brodel,2 whose classic account included 
excellent anatomic descriptions of the 
rectus abdominis muscle. They also at­
tempted to correlate anatomic factors 
with possible pathophysiologic mechan­
isms responsible for rectus-muscle rup­
ture, with or without epigastric artery 
hemorrhage.
Richardson3 described the first case 
in the United States in 1857. Since that 
time many terms have been used to de­
scribe this lesion: rupture of the rectus 
abdominis muscle, spontaneous rupture 
of the epigastric artery, spontaneous 
hematoma of the abdominal wall, spon­
taneous hematoma of the rectus sheath, 
rectus muscle syndrome, deep epigastric 
artery syndrome, and hematoma of the 
lateral abdominal wall. The common de­
nominator for all these, however, is an 
abdominal wall hematoma either within 
or lateral to the rectus muscle.4
As well as reviewing the condition, 
this report will also demonstrate that 
hematoma can occur in the flat muscles 
of the abdominal wall, as reported once 
previously,5 and describe a new tech­
nique for the diagnosis of this clinical 
entity.
Ca s e  R eports
Case 1 .— A  38-year-old Caucasian woman 
was admitted on June 18, 1969 with a 12- 
hour history of right flank pain. She had
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Fig. 1.—Case 1. Plain film of the abdomen 
before the angiogram shows a widening of the 
right lateral abdominal wall with obliteration 
of the right psoas shadow.
suffered from chronic renal failure for the 
past two years and was hypertensive. The 
pain started after strenuous coughing early 
in the morning, and radiated to the right 
hemiabdomen. She was nauseated and had 
vomited once. This thin woman had a tem­
perature of 105° F., tachycardia of 105/ 
min., blood pressure of 180/110 mm. Hg 
and a tender mass, 10 x 15 cm., over the 
right flank. Rectal and vaginal examina­
tions were non-contributory. The hemoglo­
bin level, which previously had been 6 to 
7 g./lOO ml., was 4.8 g./lOO ml. and the 
hematocrit level had fallen from 25% to 
15%. The leukocyte count was 14,100/c. 
mm., blood urea nitrogen was 80 mg./lOO 
ml. and creatinine was 12.9 mg./lOO ml. A 
plain film o f the abdomen showed a widen­
ing of the right lateral abdominal wall with 
obliteration of the right psoas shadow (Fig.
1 ) . Aortography was done on the same day 
via the right common femoral artery. In 
the early phase of the aortogram the kid­
neys were not visualized and the abdominal 
contents were shifted to occupy the mid­
dle and the left side of the abdomen (Fig.
2 ) . In the late phase of the examination, 
pooling and extravasation of dye were seen 
along the course of the right fourth lumbar 
artery (Fig. 3). The diagnosis of abdomi­
nal wall hematoma secondary to spontane­
ous rupture of the right fourth lumbar
Fig. 2.—Case 1. In the early phase of the 
aortogram the kidneys are not visualized, the 
right lobe of the liver is displaced medially and 
the abdominal contents are shifted to the mid­
dle and the left side of the abdomen.
artery was made. The patient responded 
well to conservative treatment with ice 
packs, sedation, bed rest and three units of 
blood. After two days a blue discolouration
Fig. 3.—Case 1. In the late phase of the 
aortogram the pooling and the extravasation 
of dye are evident along the course of the 
fourth right lumbar artery.
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Fig. 4.—Case 1. Two days after admission 
a blue discolouration appeared over the swell­
ing in the posterior right flank.
appeared in the right flank (Fig. 4). She 
was discharged five days later after re­
ceiving her regular hemodialysis treatment. 
When the patient was seen two months la­
ter she was asymptomatic and the mass in 
the right flank was partly resolved.
Case 2.— A 66-year-old Caucasian woman 
was admitted on May 14, 1970 with a two- 
day history of right flank pain, and a blue 
discolouration of the lower part of the right 
lower quadrant, the groin and lateral thigh 
(Fig. 5). Her blood pressure was 190/115 
mm. Hg, she was obese and had suffered 
from chronic tracheobronchitis for many 
years. She had had a myocardial infarction 
two years previously and was on anticoagu­
lant therapy. There was absolutely no his­
tory of trauma, except coughing. On admis­
sion her vital signs were stable, hemoglo­
bin and hematocrit levels were normal. 
The pain was moderate and there was ten­
derness around a mass 5 x 10 cm. in the 
right lower quadrant. Anticoagulants were 
discontinued and the patient responded 
well to conservative treatment. She was 
discharged after five days.
Case 3.— A 47-year-old man was ad­
mitted in December 1969 with a two-year 
history o f claudication in the left leg. 
Through a midline incision a left common 
iliac endarterectomy was done for limited 
segmental arteriosclerotic disease. In clos­
ing the abdominal wall large retention su­
tures were placed. Before closure of the
Fig. 5.—Case 2. Blue discolouration of the right lower quadrant and the lateral thigh on 
admission. The mass is situated above the inguinal ligament, lateral to the rectus muscle.
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skin, persistent ooze was noted around one 
suture on the left side below the umbilicus, 
with a swelling in that area. The incision 
in the anterior rectus sheath was reopened 
and bleeding from an iatrogenic tear of 
the left deep epigastric artery was con­
trolled by ligating the vessel between the 
line of Douglas and the umbilicus. The 
fresh rectus sheath hematoma was evacu­
ated and the wound closed. His postoper­
ative course was uneventful.
A natom y
A review of the anatomy of this area 
is necessary for a full understanding of 
the causes and effects of the abdominal 
wall hematoma. The anterolateral abdo­
minal wall includes the rectus abdominis 
muscle, the pyramidalis, and the “ flat” 
abdominal muscles, namely external 
oblique, internal oblique and transver- 
sus abdominis muscle. The rectus muscle 
extends from the xyphoid process and 
the fifth, sixth and seventh costal carti­
lages to the pubic ramus. It is usually 
divided into four independent masses by 
the three transverse tendons, and the 
muscle can contract vigorously.
The rectus sheath is formed through 
fusion of the flat tendons of the three 
broad abdominal muscles. At its lateral 
margin, semilunar line (linea semi­
lunaris Spigeli), the sheath has from 
five to eight perforations through which 
the intercostal nerves and vessels enter.
The anterior leaf of the sheath covers 
the entire ventral surface of the rectus 
and is stronger caudad than cephalad. 
It is intimately adherent to all the trans­
verse tendinous intersections and also 
to the lateral and medial margins of the 
muscle.
The posterior leaf consists of the flat 
tendon of the transversus muscle and 
the posterior one-half of the internal 
oblique tendon. It is shorter than the 
anterior leaf and ends in a semicircu­
lar line ( linea semicircularis Douglasi) 
about 5 cm. below the level of the um­
bilicus. The lower, tapering part of the 
rectus, which is the strongest portion of 
the muscle, is separated from the abdo­
minal viscera by only the thin and filmy 
peritoneum and extraperitoneal adipose 
tissue, reinforced by the transversalis
fascia. Hematomas in this area can 
easily cause peritoneal irritation.
The external and internal oblique and 
transversus abdominis muscles form the 
encircling musculature, while the rec­
tus and pyramidalis muscles are impor­
tant in flexion and stabilization. The 
actions of the recti are shared with the 
abdominal oblique and the transversus 
muscles. These muscles act as efficient 
protectors of the abdominal viscera; by 
their tonicity they maintain the intra­
abdominal pressure and help keep the 
viscera in place. They play a part in 
respiration, urination, defecation and 
parturition. The rectus is a flexor of the 
vertebral column, acting in antagonism 
to the posterior spinal muscles. The size, 
shape and muscular tone of these mus­
cles vary greatly with age, sex, consti­
tution, nutrition, posture and various 
physiologic states. Great exertion is 
demanded of these muscles, especially 
the lower portion of the rectus, during 
violent coughing and vomiting, and dur­
ing straining as in defecation and urina­
tion.1'' For example, the length of the 
rectus can vary between expansion and 
contraction by as much as 17 cm. ac­
cording to Cullen and Brodel.2
The anterolateral abdominal wall re­
ceives its arterial supply from the last 
six intercostal and the four lumbar ar­
teries, as well as from the superior and 
inferior epigastric and the deep circum­
flex iliac arteries. The trunks of the 
intercostal and lumbar arteries run witv 
the intercostal, iliohypogastric and ilie 
inguinal nerves between the transversus 
abdominis and the internal oblique mus­
cles. The arterial terminations pierce 
the lateral margin of the rectus com­
partment and anastomose freely with 
the superior and inferior epigastric 
trunks. Each of these arteries is accom­
panied by two veins which are quite 
thin-walled and provided with valves. 
For additional anatomic relationships 
the reader is referred to the classic de­
scription of Cullent and Brodel.2- 7
E tiology
The exact cause of the hematoma of 
the abdominal wall is unknown.8 How-
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ever, it  seems logical to postulate th a t 
muscle disruption, vessel disruption or 
a combination of both may be involved. 
One or more of the etiologic factors 
listed in Table I usually precede the on­
set of the symptoms.
TABLE I.- E tiologic F actors in  Abdominal 
Wall H ematoma
1. Direct trauma
Blunt trauma 
Stab wounds
2. Iatrogenic
Vigorous retraction during operation 
Inadequate hemostasis 
Abdominal paracentesis 
Retention suture 
Operative trauma
3. Muscle exertion
Sudden, vigorous or uncoordinated move­
ments
Coughing, sneezing and vomiting 
Defecation, urination and sexual intercourse 
Following a convulsive seizure
4. Cardiovascular diseases
Hypertension 
Congestive heart disease 
Atherosclerosis
5. Degenerative muscle diseases and collagen 
diseases
Obesity
Infectious diseases 
Leukemias, wasting diseases 
Typhoid fever, Zenker’s muscle degene­
ration
6. Pregnancy, labour, puerperium
7. Respiratory tract infections
8. Blood dyscrasias such as hemophilia; 
anticoagulant therapy
9. Previous abdominal operation
10. Idiopathic
D irect traum a or violence may be 
responsible in a variety  of ways but 
these are not the object of the present 
discussion. O perative in ju ry  may be 
recognized during operation or, as late 
as two weeks a fte r  laparotomy, may pro­
duce a palpable mass, which could play 
an im portan t role in wound dehiscence. 
Severe muscle exertion may change the 
length of the muscle and rupture  muscle 
an d /o r vessels. Severe coughing is one 
of the most common etiologic facto rs . 10  
In pregnancy abdominal wall hematoma 
occurs m ainly in m ultipara and late in 
pregnancy. It has also been described in 
the puerperium , even w ithin half an 
hour of delivery. In pregnancy the over­
stre tch ing  of the muscles may increase 
th e ir susceptibility to the traum a of la­
bour, coughing or sneezing . 11 Many of
the patien ts who su ffe r an abdom inal 
wall hem atom a have had  previous ab­
dominal operations . 10 I t  is though t th a t  
the  developm ent of fib rous tissue post- 
operatively prevents th e  vessels from  
gliding on th e ir  course, so th a t they  a re  
subject to s tra in  as the  m uscle con­
tra c ts . 12 Vascular degenerative diseases 
and blood dyscrasias m ay also p red is­
pose to th is condition. A nticoagulant 
th erap y  may be associated w ith  hem or­
rhages into the abdominal wall as well 
as hem atom a form ation elsew here . 13
P a th o lo g y
The precipitating fac to r in m ost spon­
taneous cases seems to be inelasticity  of 
the vessel wall which, du ring  m ovem ent, 
cough or sneeze, or d u rin g  or a f te r  la­
bour, prevents the vessel from  accom ­
m odating itse lf to the rem arkab le  v a ria ­
tions in length which th e  muscles under­
go between extreme con traction  and  ex­
trem e relaxation. A m ain  vessel alone 
can be disrupted, or a muscle m ay ru p ­
tu re  together with a t least a sm all a r te ­
ria l branch. W hether the  bleeding is 
a rte ria l or venous is, fo r  the m ost p a rt, 
an academic distinction since th e  end- 
result, hem atom a form ation, is usually 
the sam e . 4
Because of the com partm entalization 
of the upper part of th e  rectus sheath , 
hem atom as th a t  develop in th is  a rea  are  
localized. Should the hem orrhage occur 
near or below the line of Douglas, the 
absence of posterior rectus sheath  
allows expansion of th e  progressively  
en larg ing  hematoma across the  m idline 
or into the pelvis. For th e  same reason, 
a hem atom a occurring between th e  in ­
terna l oblique and tran sv e rsu s  muscles 
can expand widely. A n incidental ob­
servation is the  viability of th e  fascia 
th a t  rem ains intact in large hem ato­
m as . 11
D ia g n o sis
The problem  facing the  surgeon con­
fron ted  by these cases is the estab lish ­
m ent of the diagnosis. The co rrec t p re ­
operative diagnosis is m ade ra re ly  and 
Stiles, Raskowski and H e n ry 10  rep o rt
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that a mere 17% of cases were diag­
nosed before laparotomy. According to 
Jones and Merendino,13 the condition 
is three times more common in women 
than in men; 50% of cases occur in 
the right and 83% in the left lower 
quadrant and the remainder elsewhere.
Persistent, severe and localized pain 
with tenderness are the major com­
plaints. An immobile, tender, non- 
pulsatile mass can be felt and progres­
sion in size is characteristic. Nausea 
and vomiting can occur along with a 
mild fever. Massive hematomas lead to 
hypovolemic shock and can be confused 
with a ruptured aneurysm. The mass 
may be palpable on vaginal examina­
tion.1 With contraction of the abdomi­
nal muscles, a rectus sheath hematoma 
usually remains palpable, may become 
more discrete, but also becomes im­
mobile— Fothergill’s sign.14 Ecchymo- 
sis over the mass or around the um­
bilicus (Laffont’s sign) is not uncom­
mon. One important characteristic of 
abdominal wall hematoma is the in­
crease in pain that usually occurs with 
either head elevation or leg raising. On 
the other hand, patients with intra­
abdominal conditions that mimic ab­
dominal wall hematoma do not usually 
experience the same marked increase 
in discomfort with abdominal wall con­
traction unless peritonitis is present.4
Leukocytosis, elevated serum en­
zymes and mild anemia may be pre­
sent. Backwinkel suggests preoperative 
cystography as a diagnostic aid. If the 
hematoma involves the lower portion 
of the rectus it may cause extrinsic 
pressure on the bladder. Localized 
widening of the rectus shadow or cal­
cification in it indicates acute or 
chronic hematoma.11 Angiography can 
be of great value when it is applicable, 
as in our first case.
Abdominal wall hematoma can be 
mistaken for many surgical diseases: 
tumours of the abdominal wall, ventral 
hernia, ovarian cyst, ectopic pregnan­
cy, appendiceal abscess, gallbladder 
disease, incarcerated hernia, rupture 
of an aortic aneurysm and rupture of 
a pregnant uterus.
The single most important aid in 
diagnosis of abdominal wall hematoma 
is the alertness to the possibility of its 
presence. It is a tremendous aid to 
have had a previous case.6
T rea tm en t
Many of the earlier reports concern­
ing abdominal wall hematoma recom­
mended operative intervention in al­
most all cases.4 Although surgical 
treatment remains the preferred form 
of management for many of these le­
sions, there are specific cases in which 
conservative therapy is all that is nec­
essary.
Conservative therapy will generally 
suffice in small hematomas if the cor­
rect diagnosis is reached without lapa­
rotomy. Application of an ice pack and 
bed rest will minimize the symptoms 
when hematoma formation is recog­
nized early. When recognized later, 
these lesions are best managed with 
sitz baths. Proteolytic agents may be 
used if desired.
Definite indications for surgical 
management are expansion of the he­
matoma leading to hypovolemic shock 
and when doubt exists concerning the 
correct diagnosis. There is little room 
for conservative management in the 
treatment of a postoperative abdominal 
wall hematoma whose manifestations 
necessitate removal of skin sutures, 
because in such a case the fascia is at­
tenuated or frayed.0 After surgical 
exploration the following general prin­
ciples are to be followed: evacuation 
of clots, ligation of bleeding points, ir­
rigation with saline solution, and 
drainage, the latter depending upon 
the size of dead space and the surgeon’s 
personal judgment. It is not necessary 
to open the peritoneal cavity if an in­
tra-abdominal lesion can be ruled out.
P rognosis
Although this condition has been as­
sociated with a fatal outcome, the he­
matoma usually resolves and then be­
comes encysted or perhaps calcified.16 
The fatal cases are usually associated
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with severe diseases. Preceding anti­
coagulant therapy worsens the progno­
sis. The average mortality is 4%  to 
5 % .13 In pregnant patients, however, 
the prognosis is poorer, with reported 
mortality of 12% to 51% and fetal 
mortality of 25% to 5 0 % .11- 17
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progressive 
pulmonary failure: 
a critical consequence 
of shock
The recovery of patients in shock is often complicated by a pattern of de­
teriorating pulmonary function commonly described as “ shock lung. Despite 
the restoration of haemodynamic balance and apparent stabilization of the 
acute episode, many patients develop progressive pulmonary insufficiency, 
characterized by vascular congestion, haemorrhage into the interstitium and 
alveoli, and pulmonary oedema, both interstitial and intra-alveolar.
These disruptions begin at the cellular level where lack of oxygen causes 
alterations in the oxygen-carbon dioxide exchange mechanism. The changes 
in cell metabolism lead ultimately to interstitial oedema and perivascular 
haemorrhage.1 Polymorphonuclear leukocytes aggregate in the pulmonary 
capillaries obstructing the pulmonary vascular bed. As the trapped cells 
break down, they release lysosomes, tiny subcellular particles containing 
proteolytic enzymes.1 These enzymes attack their host cell and go on to 
damage or destroy other cells.2 The resulting tissue damage may not readily 
repair itself even if the shock patient survives.
protective effects 
of corticosteroids
The key to increased survival in shock, therefore, may lie in protecting the 
pulmonary architecture through preservation of the cell. If cellular integrity 
can be maintained, the progress of pulmonary destruction may be halted 
or reversed.
Current studies indicate that massive doses of corticosteroids can effectively 
alleviate these cellular changes if administered early in the course of the 
pulmonary insult. Corticosteroids appear to minimize tissue damage and 
preserve organ function by stabilizing cellular and lysosomal membranes 
thereby preventing the release of lysosomal enzymes.3
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BILATERAL PATELLAR METASTASES FROM CARCINOMA 
OF THE MALE BREAST
C. D. KEELEY, M.D., F.R.C.S.[C], F.A.C.S.,*
Chatham, Ont.
Summary: A 67-year-old man who had had re­
moval of carcinoma of the right breast subse­
quently developed bilateral patellar metastases. 
A pathologic fracture of one patella was treated 
by patellectomy with satisfactory results. At 
the time of operation generalized carcinomatosis 
was evident.
Resume: L'auteur presente un cas de metastases 
rotuliennes bilaterales et une fracture patholo- 
gique unilateral chez une homme de 67 ans 
souffrant d'un cancer mammaire et dont une 
poitrine avait ete enlevee. Une patellectomie et 
la refection du tendon du quadriceps furent pra- 
tiquees avec des resultats satisfaisants. l.'histo- 
pathologie a permis de confirmer le diagnostic 
d'adenocarcinome metastatique. L'examen radio- 
logique des os longs et du crane a mis en evi­
dence une carcinomatose generalisee. Nous 
n'avons pu retrouver un cas semblable dans la 
litterature recente.
Cancer of the breast in the male is un­
common, occurring once for every 100 
carcinomas of the female breast. Under­
standably, pathologic fracture of the pa­
tella,1 due to secondary adenocarcinoma 
of the male breast, is even more rare 
and no cases with bilateral metastatic 
involvement of the patella were found 
during a search of the literature.2- :i 
The following report describes bilateral 
metastatic adenocarcinoma and unila­
teral pathologic fracture of the patella 
in a man with carcinoma of the breast.
Case Report
On August 26, 1971, the patient, a 67- 
year-old white man, was admitted to the 
surgical service of St. Joseph’s Hospital, 
Chatham, Ontario, complaining of pain in, 
and inability to extend, the right knee. He 
had slipped at home, without falling, and 
felt something “ give” in his right knee. 
This was followed by severe pain and swel­
ling of the joint. He was unable to bear 
weight on this leg and was brought to hos­
pital by ambulance.
‘ Chief of Surgery, Public General Hospital, 
Chatham, Ont.
Fig. 1.—A section of the primary breast neo­
plasm removed in 1967. The growth is well dif­
ferentiated and presents as a microglandular 
adenocarcinoma. Minimal secretory activity is 
evident.
He had had a right radical mastectomy 
in November 1967 for carcinoma of the 
breast. The surgical specimen had shown 
infiltrating duct carcinoma with secondary 
involvement of the axillary lymph glands 
on the same side (Fig. 1). He received ir­
radiation therapy at the Windsor Clinic of 
the Ontario Cancer Treatment and Re­
search Foundation. In January 1971 a biop­
sy of a single enlarged node in the left 
axilla proved to be adenocarcinoma, prob­
ably secondary to breast.
This alert patient had a well-healed mas­
tectomy scar with no evidence of recurrence 
in either axilla or in the anterior chest wall. 
The abdomen was soft, the liver and spleen 
were not palpably enlarged. He had gross 
swelling and discolouration of the right 
knee, otherwise his extremities were nor­
mal. Radiographs of the right knee showed 
a transverse fracture of the patella with a 
1-cm. separation of the fragments (Fig. 2). 
The bone was very osteoporotic and the ap­
pearance suggested secondary metastatic 
disease.
At operation the patella was soft and 
fragmented easily. A patellectomy and re­
pair of the quadriceps tendon were carried 
out and the leg was encased in a full-length
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Fig. 2.—Lateral view of pathologic fracture 
of the right patella.
Fig. 4.—Lateral view of the left patella show­
ing the osteolytic lesion.
Fig. 3 .-A  section from the metastatic tu­
mour found in the right patella in 1971. The 
microglandular pattern of the primary tumour
plaster cast. Histopathology confirmed the 
suspicion of metastatic adenocarcinoma of 
the patella, most likely from the breast (Fig. 
3). The patient had an uncomplicated recov­
ery from the surgical procedure. The cast 
was removed in three weeks and he started 
knee movements immediately. At eight 
weeks he was walking well with return of 
knee flexion of approximately 50°. This has 
subsequently improved. During his convales­
cence a radiologic survey o f the long bones 
and skull was done. The skull showed areas 
consistent with osteolytic and osteoblastic 
metastatic disease, the left femur showed 
metastatic disease in the mid-shaft, and the 
left tibia and fibula showed evidence of 
disease in the distal shafts. The left pa­
tella showed an osteolytic lesion with a 
“ sunburst” effect (Fig. 4).
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is reproduced and again small amounts of se­
cretory matter can be seen.
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SLIPPING OF THE CAPITAL FEMORAL EPIPHYSIS WITH RENAL RICKETS: A CASE REPORT*
PHILLIP SWITZER, M.D. and H. MICHAEL BELL, M.D., F.R.C.S.[C],Vancouver, B.C.
Summary: A 13-year-old girl with renal rickets 
had minimal slipping of the capital femoral epi­
physis. Treatment with traction together with 
management of her disease by medical meas­
ures produced an excellent result.
We recommend that children with this com­
bination of disease be given a trial of medical 
therapy before operation is considered.
Resume: Une fillette de 13 ans souffrait de ra- 
chitisme d'origine renale et presentait en outre 
un leger glissement de I'epiphyse de la tete fe- 
morale. Les auteurs ont corrige par traction le 
glissement femoral et la nephropathie par un 
traitement medical. Le resultat a ete excellent.
Les auteurs conseillent d'appliquer un traite­
ment medical d'essai dans ce complexe patho- 
logique avant d'envisager I'operation.
M uller1 in 1899 noted the association between slipped capital femoral epiphy­sis and classical rickets. Since then, few reports of this combination have ap­peared. Now, with improved treatment of renal disease, increasing numbers of patients are surviving with renal osteo­dystrophy—renal rickets. In a review of the literature Shea and Mankin2 found eight instances of slipped capital femo­ral epiphysis with renal rickets, to which they added three of their own. We lo­cated one more case in the literature2 and this paper describes a patient under our care with renal rickets and slipped capital femoral epiphysis who was treated by Buck’s traction. Her renal disease was managed medically.
Case R eport
An 11-year-old girl had chronic anemia when she presented with bronchitis and pneumonia in 1967. She also had polyuria and polydipsia. She was treated with an oral preparation of iron, with slight im­provement. In April 1969 she began to have some pain in her right hip which was
•From the Division of Orthopedic Surgery, Department of Surgery, University of British Columbia, Vancouver, B.C.
aggravated by walking and relieved by sit­ting or lying. She was able to continue her ballet lessons but her teacher noted that for the last three weeks she could not perform the finer steps.In May 1969, at the age of 13 she was ad­mitted for investigation of her renal disease and the painful hip. She was a pale, thin, prepubertal girl whose stature was in the low-normal range. Her blood pressure was 120/80 mm. Hg; her pulse and respiratory rate were within normal limits. Her optic fundi were normal. Her lungs were clear to auscultation and percussion. Her heart was not enlarged; however, there was a Grade III/VI mid-systolic murmur along the left sternal border. Examination of the abdomen was negative. The genitalia were prepuber­tal. She walked with a right-sided painful limp. There was no shortening or atrophy of the right lower limb. The right hip was not tender and had a full range of motion except for 10° to 15° limitation of internal rotation when the joint was flexed.The results of laboratory investigation were as follows: urinalysis was normal ex­cept for inability to concentrate to a speci­fic gravity higher than 1.004; hemoglobin 7.2 g./lOO ml.; blood urea nitrogen 52 mg./ 100 ml.; creatinine 5.8 mg./100 ml.; calcium 8.9 mg./lOO ml.; phosphate 5.1 mg./100 ml.; alkaline phosphatase 79 King-Armstrong units; serum sodium 148 mEq./l., potas­sium 4.1 mEq./l., chloride 110 mEq./l.The diagnosis of juvenile hereditary ne- phronophthisis4 was based on the intraven­ous pyelogram, renal arteriogram and the renal biopsy of a sibling who also had renal failure.
Roentgen examination of the skeletal sys­tem revealed the generalized changes of re­nal osteodystrophy and a slip of 1 cm. of the right capital femoral epiphysis (Figs. 1 and 2).
The patient was placed on maintenance therapy consisting of vitamin D, 50,000 units three times daily, and moderate pro­tein restriction (30 to 35 g. daily). She was treated in Buck’s traction for one month, 5 lbs. on each leg and an internal rotation force of 3 lbs. applied to the right thigh. This was followed by non-weight-bearing for a further month, after which she had
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Fig. I.—Anteroposterior and “frog” lateral roentgenogram of the pelvis showing minimal 
slip of the right capital femoral epiphysis and changes of renal osteodystrophy due to second­
ary hyperparathyroidism.
radiologic evidence of healing and was 
symptom-free. She was then placed on re­
stricted weight bearing.
Fig. 2.—Magnified view of three digits show­
ing thinning of the cortices and subperiosteal 
resorption, especially in the middle phalanges, 
indicating hyperparathyroidism.
Five months after treatment began she 
had no symptoms and no limp, and had a 
full range of motion of the right hip. Ro­
entgenogram of the pelvis at that time 
showed epiphyseal closure without further 
displacement (Fig. 3).
D is c u s s io n
We chose to manage our patient con­
servatively with diet, vitamin D and hip 
protection because the slip was minimal, 
Grade I, and we were dealing with a 
“ medically treatable”  disorder. Because 
our result was excellent, we recommend 
conservative treatment for  this condi­
tion even when the patient is not a 
surgical risk.
In agreement with most authorities, 
we believe that a minimally slipped ca-
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Fig. 3.—Anteroposterior and “frog” lateral roentegenogram of the pelvis five months after 
initiation of treatm ent showing epiphyseal closure.
pital femoral epiphysis in an otherwise normal child should be treated surgical­ly.3’ 5' 6 Satisfactory results in such children have also been obtained with non-operative treatment7 0 in this de­gree of slip. Shea and Mankin2 treated their patients conservatively because the patients were unfit for operation. Our patient’s renal disease was not se­vere enough to preclude surgical man­
agement.
The au thors acknowledge the assistance of Drs. B. J. Wood, Radiology Departm ent, and D. S. Lirenman, D epartm ent of In ternal Medi­cine, Vancouver General Hospital.
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CARBAZOCHROME SALICYLATE AS A PARENTERAL 
HEMOSTAT IN TONSILLECTOMY
W. M. McLEAN, Pharm.D.* and J. T. CAMPOLONGO, M.D.,f Ottawa, Ont.
Summary: A double-blind controlled study was 
designed to determine the clinically observable 
hemostatic effect, on children after tonsillec­
tomy, of carbazochrome salicylate (Statimo) 
injected just before operation. In the 87 children 
studied there was no significant difference 
between treated and control children. Variables 
of age, sex and surgeon were also considered.
Resume: On a tenu un essai controle a double 
insu pour determiner I'effet hemostatique qu'on 
peut observer, chez les post-operatifs (tonsillec­
tomies pediatriques) ayant regu I'injection du 
salicylate de carbazochrome. Sur 87 enfants 
observes, il n'y avait aucune difference statis- 
tiquement entre les traites et les controles; les 
variables d'age, sexe et chirurgien etaient aussi 
consideres.
To determine the possible benefits of 
carbazochrome salicylate (Statimo, 
Charles E. Frosst & Co., Dorval, Que.) 
as a parenteral hemostat in patients 
subjected to tonsillectomy and/or ade- 
noidectomy and in cases of nosebleed, 
and because the literature contained no 
substantiation of the action of similar 
forms of adrenochrome,1'4 we conducted 
a double-blind study of its effects in 
children undergoing tonsillectomy.
After operation the clinically observ­
able coagulation effects of carbazo­
chrome salicylate injection were com­
pared with a placebo—a diluted vita­
min B complex that had the same col­
our. Eighty-seven children of both 
sexes, between the ages of 2 and 11 
years, received a 1-ml. injection of A 
(placebo) or B (carbazochrome salicyl­
ate) intramuscularly one-half hour be­
fore operation. Because of a printing 
error in the study design, injection A 
was given to 40 children and injection 
B to 47 children. Otherwise, injection A
’^ Director, Drug Information and Education, 
Ottawa General Hospital, Ottawa, Ont.; for­
merly Director of Pharmacy, St. Joseph’s Hos­
pital, Guelph, Ont.
fChief, Emergency Services, St. Joseph’s Hos­
pital, Guelph, Ont.
TABLE I.—Results
Category of bleeding
0 + +  + Total
Injection A (placebo) 
Injection B (carbazo­
chrome salicylate)
12 15 13 40
20 20 7 47
32 35 20 87
(or B) was given to every alternate 
child. After operation, nurses from the 
recovery room and the pediatric ward 
noted on the data sheet their observa­
tions regarding local bleeding, categor­
ized as (1) no bleeding “ 0” , (2) small 
amount of oozing “ + ” , and (3) signifi­
cant bleeding “ + + ” (Table I).
R esults
The results are shown in Table I.
Several statistical tests were carried 
out to determine whether there was any 
significant difference between the re­
sults following injection of the placebo 
and carbazochrome salicylate:
(1) Chi square: calculated X 2 = 3.97 
(d f  =  2). This is not significant at 
either the 5%, 1% or 0.1% level, sug­
gesting that there is no difference be­
tween the effects produced by A and B.
(2) Com bining ca te g o r ie s— Chi 
square: the categories and “ + + ” 
were combined and compared with “ 0” ; 
calculated X 2 = 1.46 (d f  = 1). This 
again indicates no significant differ­
ence between A and B as regards hemo­
static effect.
(3) Partitioning the contingency table:
in both cases there is no significant 
difference between “ 0” and “ + ” , or be­
tween “ + ” and or between “ +,
+ + ”  and
(4) Score method: the result, again, 
is not significant.
(5) To determine if age or sex had 
any effect, the data were tabled accord-
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ing to these param eters. Again, there 
w as no significant difference.
(6) To determ ine the effect of sur- 
geon-to-surgeon variation in technique, 
the data  fo r individual surgeons were 
subjected to analysis and no significant 
d ifference was evident. O ther variables, 
no t available fo r analysis, were the size 
of tonsils, the  patien t’s own coagula­
tion characteristics and the nurse-to- 
nurse  observation differences.
Co n c l u sio n
The above analysis indicates th a t 
there  is no significant difference be­
tw een the effects of the two injections,
th a t is carbazochrome salicylate in jec­
tion produces no more clinical hemosta­
tic effect than a placebo.
The authors express their gratitude to Mr. 
S. C. Puri, Department of Statistics, Univer­
sity of Guelph, for the statistical analysis.
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the guesswork in evaluating the effective­
ness o f an aorto coronary vein bypass.
The BL-603 Clinical Blood Flowmeter 
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i t  is simply an extension o f a device 
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hundreds o f research applications 
throughout the world. I t  is depend­
able; designed to highest safety 
standards; simple in operation; precise 
in measurement - a complement to 
modern day cardio vascular surgery.
Biotronex Laboratory, Inc.
9153 Brookvilie Road Silver Spring, Maryland 20910 Phone: 301/588-6400
September 1973 FEMOROSAPHENOUS FISTULA 335
FEMOROSAPHENOUS FISTULA FOR MAINTENANCE HEMODIALYSIS*
H. L. M EITES, M.D., T. S. ING, M.B., T. KOVITHAVONGS, M.D. and S. G. ECONOMOU, M.D., Chicago, III., U.S.A.
Summary: A  new method for constructing an 
internal arteriovenous fistula for maintenance 
hemodialysis utilizes the femoral artery and the 
long saphenous vein. The vein is divided at the 
saphenofemoral junction and the proximal valves 
within it and the proximal branches from it are 
removed. The proximal end of the vein is anas­
tomosed end-to-side to the artery and the vein 
itself then placed in a subcutaneous position. In 
the three functioning fistulas we have con­
structed, flow rates have been satisfactory and 
there has been no evidence of cardiac decom­
pensation.
Resume: Une nouvelle methode de creer une 
fistule arterioveineuse interne pour I'hemodialyse 
d'entretien utilise I'artere femorale et la longue 
veine saphene. La veine est divisee au niveau de 
la jonction saphenofemorale. On supprime les 
valvules proximales qui y siegent et les branches 
proximales qui en naissent. On procede a une 
anastomose termino-laterale du but proximale 
de la veine avec I'artere et on place alors la 
veine elle-meme en position sous-cutanee. Dans 
les trois fistules fonctionnelles que nous avons 
creees, le debit sanguin a ete satisfaisant et 
nous n'avons note aucun signe de decompen­
sation cardiaque.
IN order to gain repeated access to the circulation for maintenance hemo­dialysis, the thigh is frequently resort­ed to after the use of conventional sites in the forearms and legs is no longer feasible. For example, the distal end of a loop of the mobilized saphenous vein has been anastomosed to the femoral artery to form an internal fistula.1' 2 In search of new modes of vascular ac­cess, we have constructed a new type of internal femorosaphenous fistula.
*From the D epartm ent of General Surgery and Renal and N utrition Section, D epartm ent of Medicine, Rush-Presbyterian-St. Luke’s Medi­cal Center and Rush Medical College, Chicago, 111., U.S.A.
R eprint requests to: Dr. S. G. Economou, 1753 W est Congress Parkway, Chicago, Illinois 60612, U.S.A.
S u r g ic a l  T e c h n iq u e
Spinal anesthesia is preferred. A ver­tical incision is made over the course of the long saphenous vein from the groin to just above the knee. All but one of the proximal branches of the exposed vein are ligated and divided; this re­maining branch is cannulated for later use. The perforating branches to just above the knee are also ligated and div­ided. The distal perforating branches are left intact because they provide the channels through which arterial blood from the fistula will return to the ven­ous system.The saphenous vein is occluded tem­porarily at the knee and divided at the
Fig. 1.—The completed end-to-side anastom ­osis between the  long saphenous vein and the  fem oral a rte ry  in the le ft thigh. A—fem oral a rte ry ; V—upper arrow shows ligatu re  a t  the junction of the saphenous and fem oral veins, lower arrow  shows the saphenous vein; points to the anastomosis.
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V A. V  A.
Fig. 2.—Diagrammatic rendition of the op­
eration. On the left, the normal anatomy is 
shown. V—femoral vein with the long saphen­
ous vein entering it; A—femoral artery. On 
the right is shown the completed operation. 
Two valves and one perforator have been re­
moved and the saphenous vein has been anas­
tomosed to the femoral artery. Notice that 
now blood flows from the artery into the 
saphenous vein and proceeds in a caudal flow 
until it enters a perforator (or perforators) 
to return through the femoral vein.
saphenofemoral junction. The defect 
in the femoral vein is closed with a con­
tinuous stitch of arterial suture. While 
gently occluding the vein where it is 
divided, we inject saline retrogradely 
through the cannulated tributary and 
locate the valves in the vein. These can 
then be ruptured with a vein strip­
per or excised through a venotomy. The 
occluding venous clamp just above the 
knee is removed while saline continues 
to be injected through the cannula. This 
establishes the ease of run-off which, 
if desired, can be verified by venog­
raphy done while the patient is on the
ing the fistula.
operating table. When the patency and 
run-off of the vein have been confirmed, 
the cannulated tributary is ligated. The 
vein is then anastomosed end-to-side to 
the femoral artery at the most conveni­
ent adjacent point (Figs. 1 and 2).
The now arterialized vein with retro­
grade flow is brought to a more super­
ficial position by approximating suffi­
cient subcutaneous tissue beneath it so 
that it lies just under the skin for easier 
venipuncture. The fistula should not be 
used until the wound is healed and the 
edema has subsided.
R esu lts  an d  D iscussion
We have constructed the fistula de­
scribed in three female patients. We 
usually obtained blood inflow for the 
artificial kidney from the fistula and 
returned the blood to the patient via 
any accessible large superficial vein. 
The first fistula was created in Novem-
September 1973 FEMOROSAPHENOUS FISTULA 337
ber 1970 and had been in use for six 
months when the patient underwent a 
successful renal transplantation. Unfor­
tunately, the graft functioned for only 
14 months and maintenance dialysis re­
lying on the same fistula had to be re­
sumed in July 1972. Since construc­
tion, the fistula has generated several 
large venous channels on the antero­
medial aspects of the knee and thigh. 
Performing venipunctures on these ves­
sels has been an easy procedure. At pre- 
seift, the fistula is still functioning sat­
isfactorily. In the second and third pa­
tients fistulas have been used success­
fully for two months and two weeks 
respectively. A radiograph of a fistula 
is depicted in Fig. 3.
The pressure in the fistula is close 
to systemic blood pressure level, but 
there is no impediment to flow in case 
one chooses to return blood to the pa­
tient via the fistula. Flow rates through 
the fistula have been adequate to meet 
the usual demands of 200 to 300 ml./ 
min. required for dialysis. No evidence 
of cardiac decompensation has been ob­
served so far in spite of a positive 
Branham’s sign in all three patients and 
an average increase in cardiac output 
of 2.5 l./min. demonstrable after release 
of digital compression of the fistula in 
each of the first two patients. The first 
patient, however, has recently shown 
mild edema of the leg on the side of 
the fistula.
Since there exists the possibility of 
cardiac embarrassment from the large 
shunt, the procedure warrants consid­
eration only after the conventional 
methods of obtaining vascular access 
have been completely exhausted.
We wish to thank Drs. J. Petasnick for per­
formance of the arteriogram and A. Susmano 
for cardiac output determinations.
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AXILLOFEMORAL AND FEMOROFEMORAL BYPASS: 
AN ALTERNATIVE TO CONVENTIONAL 
AORTOILIAC REVASCULARIZATION*
NATHAN M. SHEINER, M.D., C.M., F.R.C.S.[C] and 
JACK ZELTZER, M.D., C.M., M ontreal, Que.
Summary: Twenty-three femorofemoral grafts and 
and seven axillofemoral grafts were performed 
in 30 patients with aortoiliac vascular disease. 
Of these patients 90% were unsuitable for con­
ventional revascularization. In two-thirds of them 
the primary indication for operation was limb- 
threatening ischemia. Twenty-one of the 23 
femoral grafts were patent after an average 
follow-up of 11 months. Six of the seven axillo­
femoral grafts were patent after a follow-up of 
10 months.
There were no operative deaths and none in 
the follow-up period. Complications were minor. 
Because of these encouraging results our indica­
tions for this procedure are becoming more 
liberal.
Resume: Nous avons pratique 23 greffes femoro- 
femorales et sept greffes axillofemorales chez 
30 malades presentant une maladie vasculaire 
aorto-iliaque. Parmi ces malades, 90% ne pou- 
vaient subir la revascularisation classique. Chez 
deux-tiers de ces malades, ('intervention etait 
indiquee par une menace d'ischemie des mem- 
bres. Apres une periode post-operatoire de 11 
mois, 21 des 23 greffes femorales etaient demeu- 
rees permeables. Quant aux greffes axillofemo­
rales, six sur sept etaient restees permeables 
apres 10 mois.
Nous n’avons enregistre aucun deces per- 
operatoire et aucun deces durant la periode de 
post-observation. Les complications ont ete 
mineures. Ces resultats encourageants nous ont 
incite a appiiquer davantage cette methode.
T h e  conventional treatment of aorto­
iliac vascular disease involves either en­
darterectomy or bypass of the diseased 
segments. The long-term results of these 
procedures are excellent and in good- 
risk patients they can be carried out 
with a reasonable morbidity and mor­
tality. However, in less ideal patients 
these procedures are accompanied by a 
number of disadvantages. Firstly, they
♦From the Department of Cardiovascular and 
Thoracic Surgery, Jewish General Hospital, 
Montreal, Que.
Presented at the Annual Meeting of the Royal 
College of Physicians and Surgeons of Canada, 
Toronto, Ont., January 1972.
are operations of considerable magni­
tude and, in patients with generalized 
arteriosclerosis, may be complicated by 
myocardial infarction or a cerebrovas­
cular accident. Secondly, in the obese 
patient they may be technically difficult 
and associated with an increased inci­
dence of complications of many types. 
Thirdly, the direct handling of a mark­
edly calcified, atherosclerotic aorta may 
produce distal embolization. Conse­
quently an alternative to conventional 
aortoiliac revascularization is highly de­
sirable in selected patients. Two such 
procedures are available: the axillo­
femoral bypass introduced by Blaisdell 
and Hall,1 and the femorofemoral by­
pass introduced by Vetto ;'2 perhaps both 
have a defined place in the repertoire of 
the vascular surgeon.
Because the early reports of these 
operations were encouraging, we evalu­
ated them in 30 patients at the Jewish 
General Hospital, Montreal. The first 
of these procedures was performed in 
January 1970 and the last in May 1972.
C a s e  M a t e r ia l
Of these 30 patients, 25 were men 
and five were women. The average age 
was 67 years with a range of 50 to 80 
(Table I). The patients were divided 
into two groups: Group I comprised 23 
patients with unilateral iliac artery 
stenosis or obstruction. A femorofemo­
ral bypass was done in 22 of these and 
an iliofemoral bypass in one. In this 
last patient a retroperitoneal graft 
above the bladder joined the left iliac 
artery to the right profunda artery. 
Three patients in this first group had 
had a previous aortofemoral graft for 
unilateral iliac artery obstruction and 
subsequently developed obstruction in 
the opposite iliac artery. In them a 
femorofemoral graft was inserted be­
tween the aortofemoral graft and the 
opposite femoral artery.
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TABLE I. Age, Sex and Follow-Up Period in 30 P atients With Axillofemoral and F emorofemoral
Grafts
No. of 
patients
Axillofemoral.............................................. 7
Femorofemoral.................................. 22)
) 23
Iliofemoral..................................................  1)
Group II included seven patients who 
had an axillofemoral bypass. They had 
abdominal aortic or b ilateral iliac a r ­
tery  obstruction and thus were unsu it­
able for femorofemoral g rafting . Four 
had a unilateral and th ree  a b ilateral 
axillofemoral bypass. Two of these 
seven had thrombosed aortofem oral bi­
furcation g rafts, one inserted five years 
and one th ree years before.
TABLE II.— Primary Indication for Operation
Indication Afo. 0f  patients
Frank gangrene......................... 5
Impending gangrene................  8
Severe rest pain........................  7
Disabling claudication.............  10
Table II shows the indications fo r 
these operations. Tw o-thirds were done 
in patients who had severe ischemia and 
were threatened with am putation. All 
10 patients in whom the operation was 
done because of disabling claudication 
alone had femorofemoral bypass. These 
patients were operated on in the la tte r 
half of th is study when our indications 
became more liberal.
Table III shows the associated m ed­
ical conditions in these 30 patients. 
Twenty-seven were considered unsu it­
able, on medical grounds, fo r conven­
tional aortoiliac revascularization. In 
addition many of these patients were 
on medications such as diuretics, digi­
talis, an tiarrhythm ic agents, antihyper-
TABLE III.—Associated Medical Conditions 
in 30 Patients
Condition AVi. of patients
Diabetes mellitus...................... 13
Hypertension............................  12
Coronary artery disease..........  22
Pulmonary disease 3
Extreme obesity........ 5
Renal disease............................  4
Sex Average age Average follow-up
M  F (years) (months)
5 2 69 10
20 3 66 11
tensives and coronary vasodilators. 
Twenty-two of these pa tien ts  had ab ­
norm al electrocardiogram s.
T e c h n i q u e s  of O p e r a t i o n
The technical aspects of these opera­
tions have been described elsew here1' 4 
but certain  points requ ire  re-em phasis. 
The axillofem oral g ra f ts  were all p e r­
form ed under light general anesthesia, 
and the fem orofem oral bypasses under 
light general o r epidural anesthesia. F o r 
the la tte r  we used vertical incisions in 
both groins with medial suprapubic  ex­
tensions. The diseased or “ rec ip ien t” 
side is explored firs t and the  common
side to the common fem oral artery  on the 
“ donor”  side using- a synthetic suture.
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femoral, superficial femoral and pro­
funda arteries are isolated. Since, in 
many of these patients, the superficial 
femoral arteries are occluded, the run­
off of the graft is via the profunda art­
ery. The non-diseased (“ donor” ) side 
is then explored and if the quality of 
the pulse in the “ donor” common femo­
ral artery is doubtful, we take a pres­
sure reading in the artery and compare 
it with the arm pressure. If the differ­
ence exceeds 5 mm. Hg, another ap­
proach is used. A 9.5-mm. or 10-mm. 
knitted Dacron graft is preclotted in the 
usual fashion. The patient is then given 
5,000 to 7,500 units of heparin intra­
venously and the graft is anastomosed 
end-to-side to the common femoral 
artery on the “ donor” side using a syn­
thetic suture (Fig. 1). The graft is 
placed in a subcutaneous suprapubic 
tunnel and, after its length has been 
carefully adjusted, it is clamped adja­
cent to the suture line, and blood flow 
is restored in the “ donor” limb (Fig. 
2). Then the graft is anastomosed end- 
to-side to the common femoral artery 
on the diseased side, the posterior wall 
of the anastomosis being sutured from 
within.
We have made a special point of not 
“ endarterectomizing” the common fe­
moral or profunda artery unless it 
seems absolutely essential. There is a 
greater frequency of false aneurysms 
when a graft is anastomosed to an en- 
darterectomized vessel. We also make a 
1-cm. incision into each inguinal liga-
Fig. 2.—After completion of the first anas­
tomosis a clamp is placed on the graft adja­
cent to the anastomosis and blood flow re­
stored down the donor limb.
GRAFT
common fem.art. k
deep femoral art femoral art.
Fig. 3.—The completed axillofemoral bypass 
is demonstrated diagrammatically. The course 
of the graft is illustrated in Fig. 4.
ment at the point where the graft 
crosses it. This maneuver will prevent 
the inguinal ligament from compressing 
the graft. In the three instances in 
which a bypass was constructed in pa­
tients who had a functioning unilateral 
aortofemoral graft, it was attached to 
this graft using a partially occluding 
clamp so as to maintain flow through 
the graft. Fortunately, when the orig­
inal aortofemoral bypass was performed 
in these patients a 12-mm. graft was 
used, which permitted partial occlusion.
The axillofemoral bypass followed the 
technique of Blaisdell and Hall1 (Fig. 
3). The axillary artery is exposed 
through an oblique incision just below 
the clavicle. After incising the coraco- 
clavicular fascia, the first portion of 
the artery is exposed; the pectoralis 
minor muscle is partially incised to per­
mit isolation of a longer segment of the 
vessel. The anastomosis to the axillary 
artery is made as far proximally as pos­
sible to prevent excessive motion of the 
anastomosis during arm movements. A 
long tunnel is made along the anterior
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Fig. 4.—The graft must be placed along the 
anterior axillary line and not across the most 
prominent portion of the costal arch (redrawn 
from Mannick JA, Williams LE and Nabseth 
DCS).
axillary line between the pectoralis ma­
jor and minor muscles. A small counter­
incision is made midway between the 
axillary and the femoral incisions. The 
remainder of the tunnel is then placed 
subcutaneously, superficial to the ex­
ternal oblique fascia. The graft is anas­
tomosed end-to-side to the common 
femoral artery. If a bilateral axillo- 
femoral bypass is planned, a side limb 
is inserted between the axillofemoral 
graft and the opposite femoral artery, 
in a suprapubic subcutaneous position.
Mannick and Nabseth5 have empha­
sized two points in the technique of the 
axillofemoral graft: First, the graft is 
located along the anterior axillary, not 
the mid-clavicular line (Fig. 4). If the 
graft is placed so far anteriorly that it 
crosses the most prominent part of the 
costal arch, it may be compressed by 
the arch during certain body move­
ments. Second, the surgeon must avoid 
excessive tension on the graft because 
this will kink the axillary artery and 
induce thrombosis (Fig. 5).
R e s u l t s
In the series of 30 patients there were
Fig. 5.—The importance of preventing ex­
cessive tension is illustrated in this figure 
(redrawn from Mannick JA, Williams LE, 
Nabseth DC3).
no deaths either in the early postopera­
tive period or during follow-up. Of the 
23 femorofemoral grafts, 21 were patent 
after an average follow-up of 11 
months. Two grafts became occluded, 
one within the first 24 hours and the 
second between the third and fourth 
months. In the first case the vessels on 
the “ recipient” side were severely dis­
eased and the only patent vessel was 
the profunda artery. There was mini­
mal backflow from this vessel and, in 
spite of extensive endarterectomy of the 
profunda, it remained poor. Ultimately 
the leg was amputated. The second oc­
clusion was also related to severely 
diseased vessels in a grossly obese pa­
tient ; after occlusion of the graft se­
vere claudication and rest pain recurred. 
All 21 patients with patent femoro­
femoral grafts improved considerably. 
Ischemic lesions healed promptly and 
rest pain disappeared. Of the patients 
grafted for claudication alone, claudica­
tion persists in two, although they now 
can walk a much longer distance and 
are to be considered much improved.
Of the seven axillofemoral grafts, six 
have remained patent during an aver­
age follow-up of 10 months. The only 
occluded graft was in our first patient; 
here only the profunda was patent and 
the failure was probably due to imper­
fect technique. This patient required an 
above-knee amputation. All six patients 
with patent grafts are doing well and,
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Overcome this problem in hospital treatment of surgical infections, osteomyelitis 
and other serious infections.
A GOOD SOLUTION
uncocin
Lincocin is effective against virtually all types of staphylococci including both peni­
cillinase and non-penicillinase-producing strains.
Sensitivity of Staph, aureus to Lincocin1 
7516 Strains Tested
7065-94% sensitive
451-6% resistant
“ ...if one examines the total number of strains of S. aureus tested in vitro for ac­
tivity of lincomycin we find that 7516 strains have been tested and reported. Of the 
7516 strains, where data is available, 7065 (94 percent) reported as sensitive and 
only 451 (6 percent) reported as resistant. For any antibiotic which has been avail­
able since 1962, this is a fairly impressive record.”
1. Herrell, W. E., Lincomycin. (1969). Mod. Scientific  Publ.,Chi., p. 28.
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Lincocin Sterile Solution Compatibilities with I.V. Solutions
Lincocin (600 mg -  2 ml and 1800 mg -  6 ml) was found to be physically compatible with 
500 ml of the following solutions for a period of 24 hours at room temperature.
5% Dextrose in Water 10% Dextrose in Saline Ringer's Solution
5% Dextrose in Saline Invert Sugar 10% Sodium Lactate 14 Molar
10% Dextrose in Water Polysal Travert 10% Electrolyte No. 1*
PolysaI M with 5% Dextrose
•Compatibility was determined by a study which indicated no appreciable change in the pH of the resultant mixture and no loss of 
potency of the lincomycin when diluted as indicated above.
Compatibilities Of Lincocin With Other Injectable Preparations In Infusion Solutions 
For A Period Of 24 Hours At Room Temperature
Where indicated, compatibility studies have been made using the trademarked products speci­
fied. Other branded products, although generically similar, may employ different formulas, and 
may not be compatible with Lincocin. The information reported is obtained with products on 
sale in Canada, and refers to physical compatibility and not biological activity.
C o m p a t i b i l i t y C o m p a t i b i l i t y
w i t h  2  m l w i t h  6  m l
S . S .  L i n c o c i n S . S . L i n c o c i n
D r u g Q u a n t i t y I n f u s i o n  S o l u t i o n 6 0 0  m g 1 8 0 0  m g
C a r b e n ic ill in  (Pyopert) 2 g D e xtro se  5 % ,  5 0 0  m l S a t is fa c to ry S a t is fa c t o r y
C e p h a lo r id in e  (Ceporan) 2 5 0  m g D e xtro se  5 % .  5 0 0  m l S a t is fa c to ry S a t is fa c to r y
C e p b a lo th in  S o d iu m  (K eftin ) 1 6 D e xtro se  5 % ,  5 0 0  m l S a t is fa c to ry S a t is fa c t o r y
C h lo ra m p h e n ico l So d iu m  S u c c in a te 1  e D e xtro se  5 % ,  5 0 0  m l S a t is fa c to ry N o t d e te rm in e d
(C h lo ro m y ce tin ) 
C lo x a c ill in  (O rben in) 2 5 0  m g D e x tro se  5 % ,  5 0 0  m l S a tis fa c to ry N o t  d e te rm in e d
H y d ro co rtiso n e  I.V . (S o iu -C o rte f M .O.V.) 1 0 0  m g D e xtro se  5 % ,  5 0 0  m l S a tis fa c to ry • N o t d e te rm in e d
H y d ro co rtiso n e  I.V . (S o lu -C o rte f  M .O.V.) 2 5 0  m g D e x tro se  5 % ,  5 0 0  m l S a t is fa c to ry N o t d e te rm in e d
H y d ro co rtiso n e  I.V . (S o lu -C o rte f  M .O.V.) 5 0 0  m g D e x tro se  5 % ,  5 0 0  m l S a t is fa c to ry N o t d e te rm in e d
H yd ro co rtiso n e  I.V . (S o iu -C o rte f  M .O.V.) 1 g D e x tro se  5 % ,  5 0 0  m l S a tis fa c to ry S a t is fa c t o r y
M e th ic illin  S o d iu m  (S ta p h c ill in ) l g D e xtro se  5 % ,  5 0 0  m l S a t is fa c to ry S a t is fa c t o r y
M e th y lp re d n iso lo n e  I.V . (S o lu -M ed ro l M .O.V.) 4 0  m g D e x tro se  5 % ,  5 0 0  m l S a tis fa c to ry N o t d e te rm in e d
M e th y lp re d n iso lo n e  I.V .(S o lu -M e d ro l M .O.V.) 1 2 5  m g D e xtro se  5 % ,  5 0 0  ml S a t is fa c to ry N o t d e te rm in e d
M e th y lp re d n iso lo n e  I.V . (S o lu -M e d ro l M .O.V.) 5 0 0  m g D e x tro se  5 % ,  5 0 0  m l S a tis fa c to ry N o t d e te rm in e d
M e th y lp re d n iso lo n e  I.V .(S o lu -M e d ro l) 1 g D e xtro se  5 % ,  5 0 0  m l S a tis fa c to ry S a t is fa c t o r y
O x y te tra c y c lin e  H CI (T e rra m y c in  I.V .) 0 .5  g D e x tro s e  5 % ,  5 0 0  m l S a tis fa c to ry S a t is f a c t o r y .
P e n ic i ll in  G P o ta ss iu m 5 0 0 ,0 0 0 D e x tro se  5 % ,  5 0 0  m l S a t is fa c to ry N o t d e te rm in e d
(P e n ic ill in  G, A y erst) U n its
P e n ic ill in  G P o ta ss iu m 1 m illio n D e x tro se  5 % ,  5 0 0  m l S a tis fa c to ry N o t d e te rm in e d
(P e n ic ill in  G, A yerst) U n its
So d iu m  A m p ic il lin  (P e n b rit in ) 5 0 0  m g D e x tro se  5 % ,  5 0 0  m l S a tis fa c to ry S a t is fa c t o r y
T e tra c y c lin e  H CI (A ch ro m yc in ) 0 .5  g D e xtro se  5 % ,  5 0 0  m l S a t is fa c to ry N o t d e te rm in e d
a
Lincocin prescribing information
Indications: Infections caused by Gram-positive organisms which are susceptible to the action of Lincocin, particularly staphylococci 
(including penicillinase-producing staphylococci), streptococci, and pneumococci. Not active against Streptococcus faecalis, yeasts, or 
Gram-negative organisms including N. gonorrhceae and H. influenzae.
DOSAGE AND ADMINISTRATION 
Lincocin Sterile Solution:
Intramuscular Intravenous
Adults 600 mg (2 ml) 600 mg (2 ml)
Mild every 24 hours every 8-12 hours*
Severe 600 mg (2 ml) 600-2100 mg (2-7 ml)
every 12 hours every 8-12 hours*
Children** 5 mg/lb every 5 -10  mg/lb/day in two to three
Mild 24 hours doses at 8-12 hour intervals.*
Severe 5 mg/lb every For severe infections these
12 hours doses may have to be increased
Cautions: Generally well tolerated. With oral administration, gastrointestinal side effects have been encountered such as loose stools or 
diarrhoea, nausea, vomiting, and abdominal cramps. Other minor side effects have been observed infrequently. Side effects such as neu­
tropenia, leukopenia, agranulocytosis and hypersensitivity reactions have been observed on rare occasions. Should not be used in patients 
sensitive to clindamycin.
Pending further clinical experience, Lincocin is not recommended in the newborn, in the prophylaxis of a recurrence of rheumatic fever, 
and in patients with pre-existing kidney, liver, endocrine, or metabolic diseases. Since safe conditions for the parenteral use of Lincocin 
in pregnancy have not been established, its use in such patients should involve careful consideration of expected benefits and possible 
risks. Detailed information is available on request.
Lincocin Sterile Solution: Each ml contains lincomycin hydrochloride equivalent to 300 mg lincomycin base, in 2 ml and 10 ml vials.
‘ Lincocin should be added to 250 ml or more of 5%  glucose in 
water or normal saline and given as an infusion over a period of 
30-120 minutes. When doses of 4 grams or more are given Linco­
cin should be diluted in 500 ml of fluid and administered at a rate 
not to exceed 100 ml/hour. Doses as high as 8.4 grams per day 
for 7 days in four divided doses of 2100 mg in an infusion of 250 
ml of normal saline over a period of 120 minutes were well toler­
ated in normal volunteers.
“ Over one month of age.
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except for minor claudication after four 
and five blocks in two patients, all are 
asymptomatic. Pulses in the arm on the 
side of the axillary bypass are well 
maintained in all these patients.
Of the 23 patients with femorofe- 
moral grafts five had minor complica­
tions. There were three minor wound 
infections which were superficial and 
healed promptly after local therapy. In 
no instance did infection extend into 
the graft. In one patient a hematoma 
was evacuated from the suprapubic tun­
nel but at exploration no bleeding point 
could be found. In another a collection 
of lymph at the site of a groin incision 
required repeated aspirations.
In the axillofemoral bypass group, 
one patient developed an area of cellu­
litis around the counterincision at the 
mid-abdomen. This responded promptly 
to antibiotic therapy.
D is c u s s io n
The results in these 30 patients with 
axillofemoral and femorofemoral by­
passes are excellent even though the fol­
low-up period is short. However, Man- 
nick, Williams and Nabseth,3 Parson- 
net, Alpert and Brief,4 and Vetto0 be­
lieve that graft failure almost always 
occurs within the first six months. Man- 
nick, Williams and Nabseth3 described 
27 axillofemoral grafts followed from 
one to four years with only three fail­
ures. Vetto,0 in 27 femorofemoral 
grafts, and Parsonnet, Alpert and 
Brief,4 in 36 such grafts did not have 
a single late failure. Of the three graft 
failures in our 30 patients, two occurred 
in the immediate postoperative period 
and the third three months later.
We originally reserved these types of 
bypass for patients with aortoiliac dis­
ease and limb-threatening ischemia who 
were poor operative risks. However, 
the initial results were so encouraging 
and the procedure so well tolerated, that 
our indications became more liberal 
particularly with respect to the femoro­
femoral grafts. We now offer these pro­
cedures to patients with unilateral iliac 
artery disease whose only symptoms 
are disabling claudication.
After femorofemoral anastomosis one 
can anticipate a long-term patency rate 
of 85% to 90%. After the axillofemoral 
procedure the long-term patency rate is 
about 50%.3i 4- 7 Because of this differ­
ence in patency rates we limit the axil­
lofemoral bypass to those whose limbs 
are threatened by ischemia and who are 
not candidates for conventional aorto­
iliac revascularization.
We need further experience with both 
these operations. Although these proce­
dures may not be the operations of 
choice for aortoiliac revascularization, 
if the long-term results are as good as 
the early results (and the indications 
are that they may be) they may yet re­
place conventional procedures.
A d d e n d u m
Since the submission of the article, the 
prostheses have become occluded in two 
patients with femorofemoral grafts and in 
two patients with axillofemoral grafts. In 
other words, at an average follow-up of 23 
months, 19 of 23 femorofemoral grafts are 
patent and at an average follow-up of 22 
months, four of seven axillofemoral grafts 
are patent. We have also performed an addi­
tional six femorofemoral grafts and 14 
axillofemoral grafts. Five of the former 
and 12 of the latter are patent as of July 
1973. Because of these encouraging long­
term results we still maintain our initial 
enthusiasm for these operations.
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FUNDOPLICATION ALONE WILL NOT PREVENT THE 
RECURRENCE OF A HIATUS HERNIA: A CASE REPORT
ERNEST A. RYAN, M.D., Ph.D., F.R.C.S.[C], F.A.C.S. M.Surg.,*
Toronto, Ont.
Summary: A case is presented of a patient who 
suffered recurrence of a hiatus hernia originally 
dealt with successfully by fundoplication of the 
stomach. At the second operation the fundopli­
cation was found unaltered but it had migrated 
above the diaphragm, thereby preventing the 
flutter-valve mechanism which is responsible for 
its beneficial effect.
Resume: L'auteur presente une malade qui souf- 
frait d'une recidive d'une hernie hiatale aupa- 
ravant traitee avec succes par une plicature de 
la grosse tuberosite de I'estomac. Lors de la 
seconde operation, on decrouvrit que la fundo- 
plicature etait inalteree, mais qu'elle s'etait de- 
placee au-dessus du diaphragme, empechant de 
ce fait le mecanisme valvulaire d'exercer son 
action benefique.
T he procedure of fundoplication in the 
treatment of hiatus hernias was devel­
oped by Professor Nissen of Basle, Swit­
zerland. In his writings1 and in conver­
sations he has stated that fundoplica­
tion alone is all that is necessary in the 
treatment of a hiatus hernia.
Case Report
A 58-year-old woman was first seen on 
February 7, 1967, complaining of attacks 
of epigastric pain and indigestion of about 
seven months’ duration. She had previously 
undergone several operations. She had also 
had two attacks of coronary thrombosis and 
suffered from angina which required nitro­
glycerine for its relief. She complained of 
some shortness of breath.
Findings on examination were generally 
negative except for some pallor and a mildly 
positive Murphy’s sign. A cholecystogram 
showed stones in the gallbladder. A gastro­
intestinal barium series showed a moderate­
sized hiatus hernia with some reflux (Fig. 
1). She admitted she had some mild heart­
burn. Arrangements were made for her to 
have a cholecystectomy. An acute attack of
'Died, October 31, 1972. Formerly Surgeon, 
Attending Staff, Scarborough General Hos­
pital, Scarborough, Ont.
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cholecystitis developed and cholecystectomy 
was carried out without incident on March 
15. At that time the hiatal opening admitted 
two fingers easily. We did not believe that 
this was a major cause of her symptoms. 
However, in view of the large size of the 
defect and the likelihood that with time it 
would become worse and produce symptoms, 
we thought it advisable to deal with the con­
dition on the same occasion. Ideally one 
should demonstrate esophageal reflux by 
objective measurements including esophag- 
oscopy, cineradiography and tests of reflux 
pH, as well as by barium meal, before un­
dertaking the repair o f a hiatus hernia. 
However, in view of this patient’s cardiac 
status, a second operation would have seri­
ous disadvantages. To deal with the situa­
tion as expeditiously as possible, a fundopli­
cation procedure was carried out in which 
a tube about 1% inches in length formed 
from the stomach was wrapped around the 
lower part of the esophagus; nothing fur­
ther was done. The patient made a good 
recovery.
The patient was not seen again until 
four years later, in July 1971, when she 
complained of some epigastric pain and 
increasing heartburn, especially bothersome 
at night in bed. She was helped by antacids. 
This had begun about six months earlier 
after she had done a lot of lifting. She
Fig. 1.—Hiatus hernia as demonstrated be­
fore the first operation.
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Fig. 2.—The recurrent hiatus hernia with 
the fundoplication now entirely above the 
diaphragm.
stated that latterly she had been obliged to 
sit up practically all night because of 
heartburn and fluid escaping up into her 
throat. She had to eat standing up because 
otherwise she experienced pain and discom­
fort. She insisted that she had had no 
trouble from heartburn or acidity for V/% 
years after her first operation. In the in­
terim she had had another coronary attack. 
A gastrointestinal series now l'evealed a 
large recurrent hiatus hernia; the whole of 
the fundoplieated area of the stomach her­
niated through the opening in the crura up 
into the chest (Fig. 2). An operative repair 
was arranged.
At operation it was possible, without too 
much difficulty, to withdraw the whole 
area of fundoplication from the chest. The 
fundoplication, which had been carried out 
with interrupted, continuous 00 monofila­
ment nylon sutures, was intact and essen­
tially in its original condition, except that 
some mild atrophy seemed to have devel­
oped of the part of the stomach surrounding 
the lower end of the esophagus. The crura 
were approximated with interrupted, con­
tinuous no. 1 monofilament nylon sutures, 
and further sutures were introduced to at­
tach the area of fundoplication to the re­
gion of the medial arcuate ligament. The
mi
Fig. 3.—After the repair of the recurrent 
hiatus hernia, the fundoplication is now lying 
below the diaphragm.
patient withstood this procedure well. 
Afterwards she was able to eat without 
suffering any significant heartburn and 
without having to stand up. She could sleep 
using only two pillows. Further gastroin­
testinal radiographs showed the intact fun­
doplication area now to be below the 
diaphragm (Fig. 3). Thus, the simple pro­
cedure of replacing the esophagus and car- 
dioesophageal junction in the abdomen re­
lieved her symptoms.
D is c u s s io n
Fundoplication has been advocated 
by Professor Nissen and others as the 
best method of treating a hiatus her­
nia.1' 3 Recent excellent experimental 
studies3' 3 have proved that the success 
of fundoplication in preventing eso­
phageal reflux is due solely to its me­
chanical action as an effective flutter- 
valve mechanism. This being so, it 
should be equally effective in either the 
thoracic or the abdominal cavity. Recent 
evidence has confirmed that this is 
so.2- 4 6 However, in the case we report 
there was a recurrence of heartburn
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a fte r  the in tact fundoplication m igrated  
into the supradiaphragm atic area. M or­
g an3 reported a somewhat sim ilar case. 
It seems likely th a t in such a recu rren t 
case the stomach below the area of 
fundoplication is so bulky, and the ac­
tual hiatal opening so small, the tra n s ­
mission of the intra-abdom inal in tragas- 
tric  pressure through th is area is p re ­
vented so the flutter-valve mechanism 
is not activated. The acid juices can 
then passively escape up into the eso­
phagus above the area of fundoplica­
tion, producing symptoms. Therefore, 
for a fundoplication procedure to be 
effective in the chest, care m ust be 
taken th a t the h iatus is not closed so 
tigh tly  about the stomach as to in te r­
fere w ith this valvular action. If  the 
hiatal opening is closed loosely about 
the stomach, it may also be necessary 
to su ture the edges of the opening in 
the d iaphragm  to the stomach to p re ­
vent herniation of other viscera into 
the chest.
This case indicates th a t fundoplica­
tion alone is not sufficient to prevent 
the recurrence of a hiatus hernia. M any 
previous studies have called attention 
to the high failure rate  associated w ith 
simple cru ra l repairs. The two proce­
dures combined would undoubtedly be 
more effective, but not infallible.3 To 
obtain a really high success rate in the 
repa ir of h iatus hernias, it  may be ne­
cessary to combine all three of the tech­
niques th a t have been used in the past, 
namely crural repair, fundoplication 
and some form  of gastropexy. Indeed, 
this is in essence w hat H ill4- 7 has done 
in the repa ir he describes, although he 
has not emphasized tha t a type of fu n ­
doplication is actually included as an
essential p a rt  of the procedure he rec­
ommends.
C o n c l u s io n s
Fundoplication alone is no t enough to 
prevent recurrence of h ia tu s  hernia.
A fundoplication procedure in the 
chest is not necessarily effective in p re ­
venting esophageal reflux  if  the a n a t­
omy is such as to in terfere  w ith its f lu t­
ter-valve mechanism.
In th is rep o rt a fundoplication p e r­
form ed with nylon su tures rem ained in­
tac t for more than fou r years despite 
its m igration into the chest and subse­
quent replacem ent in the abdomen.
In order to obtain a sa tisfac to ry  high 
percentage of hiatal hern ia  cures it m ay 
be necessary to  combine the th ree  pro­
cedures th a t have been used in the p a s t : 
crural repair, gastropexy and fundo­
plication.
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B O O K  R E V I E W S
CLINICAL NEUROSURGERY. Proceed­
ings of the Congress of Neurological 
Surgeons, Miami, Florida, 1971. Editor- 
in-Chief: George T. Tindall. 598 pp. 
Illust. The Williams & Wilkins Com­
pany, Baltimore; Burns & MacEachern 
Limited, Toronto, 1972. $28.60.
The theme orientation of the Annual 
Meeting of the Congress of Neurological 
Surgeons necessitates that certain topics 
will inevitably reappear. Since the pro­
gram centres around the major interests 
of the honoured guest, this volume of the 
1971 Congress, which honoured E. S. 
Gurdjian, is dedicated to head and neck 
trauma. Naturally these topics have been 
covered in past volumes of “ Clinical 
Neurosurgery” but not before in such 
extent or detail.
The papers provide a pleasing mixture 
of the new with the old. Recent advances 
in the microphysiology of injured cere­
bral cells, altered cerebral circulation 
and sophisticated techniques for monitor­
ing patients with head injury are 
presented side by side with the more 
traditional chapters on pathogenesis, 
medical and surgical management, and 
prognosis of closed head injuries. Lying 
at the mid-point of the spectrum one finds 
papers that may propose a heretical solu­
tion to a classical problem (e.g. Mc- 
Laurin’s management of chronic subdural 
hematomas in infancy). At the end of this 
text are three chapters on the biology, 
investigation and disorders of memory— 
the topic of the basic science seminar 
which initiated the 1971 Meeting.
Naturally all papers have been polished 
before publication so that the reader who 
attended the meeting will find elabora­
tion of the original presentations with 
representative case histories and per­
tinent references appended to each 
chapter. A bonus included with this 
particular issue is the cumulative index 
for the previous 19 volumes.
At its annual meetings the Congress 
dedicates itself to the younger neuro­
surgeon who may not have continuing 
access to the academic community. Con­
sequently, the papers, while of a general 
nature, are topical and delivered by the 
experts. It is therefore the reviewer’s 
opinion that the annual volumes of 
“ Clinical Neurosurgery” , which l-eprio- 
duce the presented material, should form 
one of the core texts in the resident’s, 
hospital’s and neurosurgeon’s library.
R. P. H u m ph r eys  
Division of Neurosurgery,
The Hospital for Sick Children,
Toronto, Ont.
THE LANGUAGE OF FRACTURES. Ro­
bert Jordan Schultz. 394 pp. Illust. The 
Williams & Wilkins Company, Balti­
more; Burns & MacEachern Limited, 
Toronto, 1973. $24.75.
This is an unusual and interesting book. 
It is well written and clearly illustrated. 
Its aim is to aid the medical student in 
understanding fractures but it will also 
be of use to orthopedic residents and of 
interest to teachers of orthopedics.
The book is divided into four sections. 
The first deals with general matters such 
as anatomical considerations, classifica­
tion of fractures, fracture healing and 
terms related to fracture union. The 
second part deals with the application of 
these principles to specific regions of the 
body. The third part is an unusual and 
fascinating discourse on fracture ep- 
onyms which contains material of intense 
historical interest. The fourth part con­
siders “ Fractures that are not Fractures” .
It is refreshing to read a book that con­
siders problems concerned with fractures 
in a different and stimulating way.
W . H. K irkaldy-W illis
Department of Surgery (Orthopedic), 
University Hospital,
University of Saskatchewan,
Saskatoon, Sask.
THE MILWAUKEE BRACE. Walter P. 
Blount and John H. Moe. 198 pp. Illust. 
The Williams & Wilkins Company, 
Baltimore; Burns & MacEachern Lim­
ited, Toronto, 1973. $10.75.
The only serious criticism of this book 
is that it has been so long in coming to 
print. It will now be an essential addition 
to the library of any orthopedic surgeon 
who treats even the occasional patient 
with scoliosis. Those who devote a large 
part of their time to the management of 
spinal deformities will find much to help 
them in this small reasonably priced 
volume. They will most certainly pass 
their copies on to their therapists for the 
section on the associated essential ex­
ercise program, and to their orthotists for 
the chapters on brace-making. Although 
new materials will supplant the leather 
and orthoplast braces so thoroughly 
described, and prefabrication methods 
may help to speed delivery, the principles 
outlined will remain intact.
The indications for treatment with the 
brace have been spelled out clearly and 
will help to end the tendency to treat 
severe curves with no hope of success. 
This book should become the definitive
(Continued on Adv. page 31)
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one on non-operative management of sco­
liosis and kyphosis.
J. E. H all
Department of Orthopedic Surgery,
Children’s Hospital Medical Center,
Boston, Mass.
RECENT ADVANCES IN ANAESTHE­
SIA AND ANALGESIA. 11th ed. Edited 
by C. Langton Hewer. 333 pp. Illust. 
Churchill Livingstone, Edinburgh; 
Longman Canada Limited, Toronto, 
1972. $16.25.
Many changes have taken place in the 
practice of anesthesia during the years 
since the tenth edition of this book 
was published in 1967. The eleventh 
edition deals with a wide range of sub­
jects and manages to include most of the 
topics that are currently of foremost con­
cern to the practising anesthetist. Newer 
intravenous anesthetic drugs and the in­
teraction of drugs are particularly well 
covered, as are the occupational hazards 
of the anesthetist. Of necessity, the latter 
subject is dealt with briefly but most 
items are covered and the extensive bib­
liography permits the reader to study any 
specific area in greater depth.
The chapter on anesthesia and resusci­
tation in difficult environments is parti­
cularly fascinating and extremely useful 
to the anesthetist who may, on rare occa­
sions, find himself in the unhappy posi­
tion of serving in a situation that is totally 
unfamiliar to him; however, the total 
space devoted to this subject is excessive 
in a book devoted to recent advances. I 
enthusiastically recommend the final 
chapter entitled “The Present and Future 
Place of the Anaesthetist in British Hos­
pitals” to all physicians, be they surgeons 
or anesthetists, and to hospital adminis­
trators interested in the present and fu­
ture place of the anesthetist, not only in 
British hospitals but in hospitals through­
out the world. The reader will find many 
important concepts in this section whose 
author, Dr. J. Parkhouse, considers the 
validity of the equation “one anaesthesio- 
logist equals one surgical operating 
schedule” , and its converse “ one surgical 
operating schedule equals one anaesthe- 
siologist” . (“Anaesthesiologist” is used 
here in the American sense as meaning a 
specialist physician-anesthetist.)
This well-written book is recommended 
as a means of keeping up-to-date in the 
specialty and, for residents, as a review 
of the subject for examination purposes.
M. M in u c k
Department of Anesthesia,
University of Manitoba,
Winnipeg, Man.
(Continued on Adv. page 33)
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SUPPORTIVE CARE OF THE SUR­GICAL PATIENT. William M. Stahl.270 pp. Grune & Stratton, Inc., NewYork; Longman Canada Limited, To­ronto, 1972. $15.50.
This small volume describes the general support m echanism s of the body and th e ir  response to m ajo r assau lts  such as shock, hem orrhage, sepsis and trau m a  to the in terna l environm ent. I t em phasizes correction of physiologic and biochem ical abnorm alities ra ther th an  surgical tech ­niques to be employed.
The au th o r logically and effectively  considers all of the body systems as fu l­filling  p rim arily  one of th ree  functional roles: exchange (re sp ira to ry  system, a li­m entary tra c t, and k idney), tra n sp o r t (card iovascu lar system  and body f lu id s), and regu lation  (liver, endocrine glands, autonom ic nervous system  and psyche).
The dem ands from , o r con tribu tions to, body m etabolism  of m uscle, bone and cen tral nervous system  are  acknowledged as tissue function r a th e r  th an  as body systems.
Each ch ap te r covers a specific organ  or system  and deals w ith  general function , specific physiology an d  m etabolic re ­quirem ents, m easurem ent techniques, p re ­operative evaluation and  p reparation , in ­traoperative  m anagem ent and postopera­tive care, s tressing  m ain tenance of optimal function  of each  vital system.
The brev ity  with w hich the sub jec t m atter is p resented  under num erous headings and  subheadings is cou n te r­balanced by veritable Jaco b ’s sta irw ays of bibliographical re fe rences a t the end of each chapter.
The re fresh in g  and  w ell-balanced ap­proach to the  understanding , the evalua­tion and the  m anagem ent of su rg ica lly  trea ted  p a tien ts  achieved in th is book will be a resource  from w hich  neophyte in ­te rns can gain  perspective, busy residen ts can broaden th e ir academ ic horizon and the p rac tis in g  surgeons can be rem inded of the complex biological processes w hich m ust be considered in th e  m anagem ent of seriously ill patients.
This book will find a place as a “study  and reference com panion” fo r doctors in­volved in the day-to-day care of p a tien ts  in active surg ical w ards of w ell-equipped hospitals.
T . K . T h o r l a k s o n
The W inn ipe g  C linic,
W inn ipeg, M an.
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field, 111., 1973. $14.75.
Surgery of Repair as Applied to Hand Injuries.
4th ed. B. K. Rank, A. R. Wakefield and J. 
T. Hueston. 390 pp. Must. Churchill Living­
stone, Edinburgh; Longman Canada Limited, 
Toronto, 1973. $14.50.
Surgical Anatomy for Clinical Examination.
Andrew W. Munster and George J. Thomas. 
129 pp. Must. McGraw-Hill Ryerson Limited, 
Toronto; Charles C Thomas, Publisher, 
Springfield, 111., 1973. $10.75.
Transplantation Today. Volume II. Proceedings 
of the Fourth International Congress of the 
Transplantation Society, September 24-29, 
1972, San Francisco, California. Edited by 
Felix T. Rapaport, Hans Balner and S. L. 
Kountz. 1016 pp. Must. Grune & Stratton, 
Inc., New York; Longman Canada Limited, 
Toronto, 1973. $37.75.
Year Book of Surgery 1972. Edited by Seymour 
I. Schwartz and others. 508 pp. Illust. Year 
Book Medical Publishers, Inc., Chicago, 1972. 
Price not stated.
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